data_4b2v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4b2v _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.75 165.89 23.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.52 135.95 57.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.092 0.472 . . . . 0.0 111.502 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.09 -6.54 82.6 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.013 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.24 163.38 54.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.453 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.0 129.56 44.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.659 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.13 122.64 26.86 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.528 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' NE1' ' A' ' 19' ' ' TRP . 32.0 Cg_endo -62.04 169.05 8.08 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.863 2.375 . . . . 0.0 112.375 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.08 111.23 1.01 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 123.988 0.805 . . . . 0.0 112.512 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 54.0 Cg_exo -55.63 -27.87 62.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.374 2.716 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -71.2 -36.83 72.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.18 -46.19 5.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.12 -16.69 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.289 . . . . 0.0 111.582 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 154.92 31.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.516 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 13' ' ' PRO . 4.7 p-10 -88.74 130.27 35.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.081 0.467 . . . . 0.0 110.43 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.458 ' NE1' ' HD2' ' A' ' 11' ' ' PRO . 1.6 p-90 -143.2 113.57 7.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.773 0.797 . . . . 0.0 109.965 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.0 t -161.21 154.77 21.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.709 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.74 103.07 15.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 164.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 -105.09 1.13 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.067 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -144.33 144.71 31.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.673 0.236 . . . . 0.0 110.575 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 t -96.71 110.11 22.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.7 mt -130.06 122.61 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.91 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 59.34 40.06 21.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 110.663 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.0 m120 62.57 22.78 13.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.461 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.04 152.29 42.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.26 119.7 39.15 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.801 -174.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -79.51 166.42 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.15 0.5 . . . . 0.0 111.544 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 21.2 t30 -59.76 125.33 23.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.622 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.18 -7.57 52.13 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.341 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.84 156.06 51.47 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.201 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 58.8 t80 -97.68 122.53 40.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.761 0.315 . . . . 0.0 110.431 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 7.9 p -118.01 130.69 24.57 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 34.6 Cg_endo -62.98 166.65 13.77 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.28 1.987 . . . . 0.0 110.798 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -44.36 109.55 0.87 Allowed Pre-proline 0 C--N 1.329 -0.304 0 O-C-N 124.016 0.822 . . . . 0.0 111.281 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.14 -29.67 89.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.163 2.575 . . . . 0.0 113.76 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.49 -24.86 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.414 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -97.08 -45.21 6.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.5 mtt -110.47 3.76 19.89 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.88 142.47 13.16 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.543 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.1 117.58 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.505 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 5.9 p-90 -134.2 112.33 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.815 0.817 . . . . 0.0 110.549 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 42.9 t -161.07 159.46 29.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.115 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 103.81 14.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 163.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.92 -111.62 2.24 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.235 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -144.67 142.85 30.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.908 0.354 . . . . 0.0 110.819 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -98.71 111.51 23.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.251 176.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.73 114.16 46.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.037 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.72 56.75 6.37 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.503 0.502 . . . . 0.0 111.361 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 23.9 m120 66.64 19.01 10.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.424 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 36.1 tt0 -129.13 145.38 51.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 36.6 t -100.75 128.14 46.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 -177.762 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.698 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 t . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.32 163.93 21.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p-10 -61.92 133.71 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.276 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.21 4.26 84.08 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.03 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.62 153.66 24.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.951 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.56 121.75 29.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.826 0.346 . . . . 0.0 110.813 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -109.0 126.93 28.25 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.61 167.9 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.479 2.119 . . . . 0.0 111.525 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.07 107.17 0.5 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 124.167 0.917 . . . . 0.0 112.889 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.93 -26.42 74.46 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.168 2.579 . . . . 0.0 112.371 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 15' ' ' LYS . 7.0 pt-20 -57.07 -42.85 81.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.736 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 47.1 mmtm -98.82 -46.4 5.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -94.0 -5.24 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.02 155.62 26.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.066 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -78.31 96.73 5.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -125.63 112.28 15.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.161 0.981 . . . . 0.0 110.817 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 67.2 m -158.67 167.04 30.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.544 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -84.47 104.38 14.43 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 165.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -105.57 2.19 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -171.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -140.54 148.52 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.762 -0.258 . . . . 0.0 111.276 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 40.1 t -97.6 109.72 22.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.8 mt -128.8 110.64 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.377 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 63.37 39.94 8.91 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.42 0.45 . . . . 0.0 110.352 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.64 24.74 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.12 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -125.66 144.57 50.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.698 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 90.6 m -101.09 121.92 42.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.918 0.39 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.167 -179.18 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.679 HG11 ' SG ' ' A' ' 20' ' ' CYS . 4.2 p . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.294 0.569 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.13 -170.32 3.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.546 -170.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 25.7 p-10 -50.73 138.89 17.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.471 0.653 . . . . 0.0 111.885 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.5 71.67 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.787 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.33 153.07 49.02 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.148 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' A' ' 9' ' ' PHE . 81.6 t80 -99.05 131.07 45.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.236 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.7 p -132.94 143.24 47.76 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.82 164.97 27.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.28 1.986 . . . . 0.0 111.171 173.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 3.0 p-10 -52.53 112.51 3.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.718 0.636 . . . . 0.0 111.613 -177.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.5 Cg_exo -59.29 -21.51 60.76 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.492 2.794 . . . . 0.0 113.203 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 10.6 pt-20 -65.04 -40.57 95.0 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.124 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.3 mptm? -96.91 -45.92 6.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.05 0.23 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.78 161.76 23.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.949 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -89.48 114.16 25.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -137.55 109.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.523 0.678 . . . . 0.0 110.552 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.679 ' SG ' HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -164.87 174.37 10.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.08 172.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.38 104.99 14.87 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 162.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 -127.64 8.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -131.98 141.36 49.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 14.6 t -96.6 112.53 24.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.8 106.12 17.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.217 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 54.42 55.39 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.351 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.8 m120 72.16 5.52 5.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.188 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.6 143.77 50.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 73.0 m -103.08 134.3 46.74 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.107 0.48 . . . . 0.0 111.588 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.094 177.597 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.717 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 31.9 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -69.51 163.65 24.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.613 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -53.0 131.84 36.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.058 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.12 83.27 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.185 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 169.9 54.66 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.516 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -97.98 134.37 41.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.912 0.387 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -124.87 130.69 24.14 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.539 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.35 164.31 23.52 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.389 2.059 . . . . 0.0 111.092 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 56.5 m-20 -48.67 112.28 2.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 O-C-N 123.856 0.722 . . . . 0.0 112.016 -173.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 -27.3 52.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.348 2.699 . . . . 0.0 112.937 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.8 pt-20 -62.2 -40.69 96.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 5.3 tppp? -98.81 -46.22 5.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.3 mpt? -101.31 3.03 40.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.36 159.36 25.5 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.434 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 24' ' ' CYS . 12.0 t70 -86.83 106.95 18.08 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.29 111.0 9.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.627 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.06 163.17 34.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.847 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.7 m -83.78 105.61 14.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.93 -102.63 1.89 Allowed Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -143.96 149.58 36.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.989 0.116 . . . . 0.0 110.722 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 36.2 t -97.45 110.32 22.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -128.28 111.59 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.211 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 59.81 48.91 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.23 24.56 14.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.008 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -133.19 150.74 51.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.824 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.717 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 81.5 m -100.74 119.04 38.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 30' ' ' ARG . 20.7 mtp180 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.555 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 13.9 p . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.81 171.91 11.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 111.25 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -56.79 133.5 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.573 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -14.21 65.41 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.632 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.16 139.99 38.94 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.176 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.633 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 88.9 t80 -82.78 119.21 24.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.045 0.45 . . . . 0.0 110.245 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -115.54 127.03 27.13 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.759 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 26.5 Cg_endo -60.58 160.03 25.78 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.507 2.138 . . . . 0.0 111.166 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 6.2 m-20 -45.07 108.11 0.72 Allowed Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 124.357 1.036 . . . . 0.0 112.423 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -54.34 -29.08 56.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.384 2.723 . . . . 0.0 112.947 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.5 pt-20 -58.62 -38.64 78.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.93 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 24.3 tptm -99.1 -46.16 5.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.4 mpt? -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.25 146.12 5.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.492 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.55 110.01 9.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.512 ' CZ3' ' HB ' ' A' ' 4' ' ' VAL . 14.8 p-90 -128.6 112.05 13.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.109 0.956 . . . . 0.0 110.02 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.7 t -162.46 154.53 18.78 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.864 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.57 101.96 12.51 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 163.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -109.68 2.06 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.744 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.86 140.07 28.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -95.8 110.29 22.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.11 122.93 62.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.036 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 2.9 mmp_? 58.11 41.08 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.417 0.448 . . . . 0.0 110.358 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 66.66 19.36 10.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.131 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.21 151.98 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.7 t -100.48 123.42 44.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 109.909 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.167 -177.051 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.407 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 8.8 p . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.82 166.12 20.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.0 111.13 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -61.33 136.45 58.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.545 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.43 78.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.067 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.49 162.84 54.25 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.397 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 79.7 t80 -95.88 136.44 36.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.46 . . . . 0.0 110.892 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -132.24 150.87 77.19 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 18.2 Cg_endo -58.88 170.47 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.374 2.049 . . . . 0.0 111.592 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.611 ' OD1' ' HD3' ' A' ' 15' ' ' LYS . 9.0 t70 -46.22 109.05 0.91 Allowed Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.837 0.71 . . . . 0.0 111.427 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.45 -24.42 68.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.418 2.745 . . . . 0.0 113.887 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.65 -43.82 16.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.717 0.294 . . . . 0.0 110.93 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.611 ' HD3' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -86.74 -45.32 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.185 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -92.78 -22.69 19.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.5 149.48 23.54 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.508 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.96 120.14 27.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.185 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.43 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 42.1 p-90 -125.25 113.18 17.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.767 0.794 . . . . 0.0 110.606 175.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 47.0 t -160.83 173.53 15.22 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.267 173.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 55.0 m -88.31 103.72 16.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 161.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.11 -117.51 3.67 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.76 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -144.94 135.57 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.854 0.327 . . . . 0.0 111.232 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -103.65 118.1 35.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.272 0.558 . . . . 0.0 109.725 175.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -136.32 130.23 47.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.213 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 65.76 36.64 6.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.556 0.342 . . . . 0.0 111.002 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 21.3 m120 64.5 15.93 9.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -132.94 149.71 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -101.74 134.99 44.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.706 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.783 -175.23 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.642 HG11 ' SG ' ' A' ' 20' ' ' CYS . 9.3 p . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -75.31 165.84 24.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.159 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -59.99 145.3 46.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.39 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.02 -11.24 67.73 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.641 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.28 142.3 40.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.816 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -84.34 131.94 34.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.5 p -136.01 142.52 40.56 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.71 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.04 158.4 43.88 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.349 2.033 . . . . 0.0 111.01 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.45 118.5 19.18 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.59 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.68 -28.74 48.11 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.702 2.935 . . . . 0.0 113.437 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -96.6 -45.85 6.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.4 mmm -110.56 0.68 17.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.64 30.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.214 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.468 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 22.7 t70 -86.95 114.59 23.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.629 0.252 . . . . 0.0 110.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -134.76 112.15 10.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.975 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' HG11 ' A' ' 4' ' ' VAL . 16.4 t -164.11 174.91 10.73 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.604 169.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 17.2 m -84.19 103.09 13.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.09 -117.14 4.32 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -144.77 140.67 28.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.951 0.375 . . . . 0.0 111.082 -178.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.7 t -98.24 117.32 32.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.42 122.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.989 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 61.49 41.51 12.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.076 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.9 m120 67.34 7.88 5.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.255 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -128.56 148.55 50.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -102.5 147.11 27.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.317 0.58 . . . . 0.0 111.845 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.479 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.62 164.67 26.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.169 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 95.0 m-20 -59.27 133.11 55.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.235 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.75 -12.17 66.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.5 156.2 46.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.448 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' A' ' 9' ' ' PHE . 79.4 t80 -93.44 121.32 34.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.666 0.27 . . . . 0.0 110.869 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 4.3 p -129.07 126.66 23.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.915 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.49 172.09 7.18 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.725 2.284 . . . . 0.0 112.272 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 9.6 p-10 -55.56 121.51 39.09 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.401 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.23 -26.38 51.47 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.713 2.942 . . . . 0.0 113.671 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' C ' ' HE3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -68.3 -31.96 71.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -96.56 -45.47 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.584 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mpt? -114.48 0.61 14.08 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.3 152.91 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.69 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.81 119.93 30.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.206 0.527 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -122.74 112.15 17.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.673 0.749 . . . . 0.0 109.743 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.4 t -162.5 155.96 20.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.747 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.99 102.44 14.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 -109.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.127 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -139.28 146.15 40.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.292 . . . . 0.0 110.799 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.45 110.99 23.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 28.6 mt -136.14 127.49 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.965 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 25' ' ' ILE . 15.6 mtm180 62.65 33.44 15.66 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.62 0.368 . . . . 0.0 110.862 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 18.6 m120 61.97 20.65 11.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 110.811 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 32.5 mt-10 -116.38 156.23 27.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 38.4 t -102.66 119.68 39.25 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 ' HB ' ' SG ' ' A' ' 20' ' ' CYS . 47.3 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -87.68 166.42 14.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.741 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -57.25 133.97 55.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.27 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -3.11 76.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.249 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.57 148.61 49.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.011 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.64 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 55.8 t80 -89.44 130.55 35.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.786 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.7 p -124.72 147.5 56.28 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.31 170.67 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.217 1.945 . . . . 0.0 111.568 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.79 112.59 2.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.057 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 -27.23 67.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.086 2.524 . . . . 0.0 112.499 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -67.45 -33.08 74.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.114 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.65 -45.62 6.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -102.23 -14.71 16.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 155.87 25.99 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -171.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -86.3 123.55 31.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -129.53 112.46 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.555 0.693 . . . . 0.0 110.357 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 28.9 t -162.21 175.04 12.08 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.593 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.2 m -84.63 105.27 15.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 160.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.97 7.99 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -135.7 134.01 38.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -99.07 112.16 24.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 109.691 176.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.7 mt -120.13 120.55 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.892 -174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 57.08 50.38 12.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.366 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 65.3 13.28 8.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.213 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.33 147.57 52.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.8 t -102.14 137.44 40.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.406 0.622 . . . . 0.0 112.255 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.722 179.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.84 0.352 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.97 158.43 35.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.148 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -60.48 124.45 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.79 -10.14 58.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.264 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.68 152.23 52.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.384 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 48.9 t80 -92.28 128.11 38.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 0.0 110.563 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.2 p -121.38 133.4 24.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.339 -0.392 . . . . 0.0 109.991 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.58 167.88 14.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 111.939 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -42.66 109.25 0.72 Allowed Pre-proline 0 C--O 1.237 0.423 0 O-C-N 124.263 0.977 . . . . 0.0 112.613 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.86 -18.62 42.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.344 2.696 . . . . 0.0 112.641 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -62.56 -39.16 92.78 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -97.54 -45.44 6.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.75 -175.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.0 mtt -108.22 8.04 27.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.75 162.24 5.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.786 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -86.33 121.85 29.48 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -124.89 112.89 17.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.865 0.84 . . . . 0.0 109.589 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 35.5 t -160.55 163.22 32.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.654 -173.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -92.63 103.55 15.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 161.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.3 -109.97 2.4 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.023 -170.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -139.83 138.71 36.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 110.782 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -98.93 111.17 23.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 109.963 176.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.14 129.82 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.986 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 58.82 43.28 18.57 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.398 0.436 . . . . 0.0 111.006 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 28.8 m120 60.61 26.27 15.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.304 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -131.37 150.8 52.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -100.73 119.55 38.78 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.805 -174.197 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.8 -175.06 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.25 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 2.3 p-10 -51.53 132.6 30.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.333 0.587 . . . . 0.0 111.268 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.16 13.33 17.93 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.301 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.32 141.6 15.37 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.606 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 60.4 t80 -93.94 111.95 23.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.9 p -114.95 123.26 32.18 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.986 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 84.6 Cg_exo -53.94 164.43 2.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.915 2.41 . . . . 0.0 112.287 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -37.6 114.91 0.74 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 124.29 0.994 . . . . 0.0 112.711 -171.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 44.6 Cg_exo -58.56 -42.33 55.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.333 2.689 . . . . 0.0 114.028 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -81.26 -37.06 29.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.601 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -96.14 -35.93 11.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.858 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 11' ' ' PRO . 64.4 mtt -103.87 -21.96 13.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.18 144.69 6.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.566 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 14.6 t70 -98.93 106.64 18.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.731 0.301 . . . . 0.0 110.459 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.476 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 30.6 p-90 -132.06 112.19 12.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.692 0.758 . . . . 0.0 110.208 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.09 173.19 16.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.667 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 t -84.5 105.35 15.25 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.23 1.73 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.832 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 1.1 tmt_? -144.67 146.85 32.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 34.6 t -97.31 113.06 24.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.9 mt -126.6 117.71 48.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.0 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 59.46 43.42 16.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 110.65 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 20.0 m120 62.93 26.72 15.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.398 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -133.02 153.35 51.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.599 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 90.5 m -101.81 124.99 48.37 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.207 0.527 . . . . 0.0 110.629 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.733 178.293 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.565 HG11 ' SG ' ' A' ' 29' ' ' CYS . 4.1 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.51 171.84 9.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.202 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 5.2 p-10 -52.62 137.96 29.47 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.486 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.69 69.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.742 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.71 150.57 28.25 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.172 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 27' ' ' ASN . 78.6 t80 -89.92 122.77 33.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -109.81 132.33 21.44 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.06 166.16 17.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.443 2.096 . . . . 0.0 111.508 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 14' ' ' GLU . 21.1 t70 -45.46 113.08 1.8 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.049 0.843 . . . . 0.0 111.87 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.2 Cg_exo -59.45 -20.96 59.21 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.211 2.607 . . . . 0.0 113.326 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 34.9 mm-40 -74.98 -33.58 61.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.521 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -96.34 -45.28 6.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.349 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.15 -8.36 25.26 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 163.87 38.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.876 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.08 107.12 13.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -135.86 112.41 10.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.072 0.939 . . . . 0.0 111.035 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.6 m -158.96 166.7 31.2 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.9 m -84.9 103.76 14.25 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 162.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.89 -117.67 4.22 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.72 149.48 49.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.716 0.258 . . . . 0.0 110.598 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.433 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 42.9 t -97.84 109.46 22.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.85 111.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.975 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 61.65 44.69 8.69 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.42 0.45 . . . . 0.0 110.881 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 22.3 m120 62.77 28.21 16.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.396 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -132.17 144.29 50.57 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' HG11 ' A' ' 4' ' ' VAL . 92.4 m -101.25 119.0 38.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.056 -177.42 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 20' ' ' CYS . 6.6 p . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.0 167.15 20.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.325 -172.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.1 p-10 -59.26 137.21 58.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.201 0.524 . . . . 0.0 110.738 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.41 -13.39 56.9 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.533 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.46 150.31 49.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.365 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.75 124.87 39.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -116.78 134.65 22.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.984 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 30.4 Cg_endo -63.19 159.99 36.66 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 111.461 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.74 116.5 6.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.281 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.36 -28.9 55.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.538 2.825 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.93 -37.41 84.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.6 OUTLIER -97.04 -45.99 6.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 11' ' ' PRO . 2.3 mpt? -102.18 -14.41 17.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -172.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.91 167.63 36.19 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -88.71 107.3 18.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -133.35 112.18 11.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.829 0.823 . . . . 0.0 110.188 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.439 ' HA ' ' CG1' ' A' ' 4' ' ' VAL . 64.2 m -160.05 170.74 20.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.086 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.67 104.61 15.55 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 160.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.54 -113.03 3.84 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.21 -171.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -133.3 152.26 51.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.66 -0.318 . . . . 0.0 111.153 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -97.79 109.65 22.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 62.9 mt -129.16 115.92 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.248 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 60.66 40.45 16.44 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.183 0.302 . . . . 0.0 110.687 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.75 29.49 19.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.279 0.562 . . . . 0.0 110.844 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 25' ' ' ILE . 36.5 tt0 -132.61 145.57 51.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.293 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 93.6 m -100.71 122.73 43.84 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.902 -178.568 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.67 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 23.7 t . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.94 162.95 27.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.922 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 94.3 m-20 -63.28 126.98 29.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.961 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.09 -4.04 84.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.035 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.75 52.9 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.629 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 57.3 t80 -88.46 117.72 27.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 p -112.66 130.97 22.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.444 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.99 161.64 25.25 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.336 2.024 . . . . 0.0 111.136 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -51.07 123.11 18.88 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.761 0.663 . . . . 0.0 111.572 -172.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.06 -20.85 47.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.431 2.754 . . . . 0.0 114.028 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -80.84 -25.94 37.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.62 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -45.86 6.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -108.15 -10.32 15.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.12 166.42 35.57 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.818 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.5 109.12 20.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.894 0.378 . . . . 0.0 110.295 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -135.49 111.05 9.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.806 0.812 . . . . 0.0 110.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.5 m -160.75 173.63 15.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.733 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 106.02 18.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . 107.99 -106.79 2.43 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.434 ' HD2' ' C ' ' A' ' 22' ' ' GLY . 8.4 mpt_? -137.39 152.32 49.51 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.337 0.255 . . . . 0.0 110.387 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.6 t -96.92 110.2 22.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.93 120.46 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.2 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 60.07 32.8 21.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.646 0.378 . . . . 0.0 110.744 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 27.2 m120 66.13 23.49 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.853 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.82 151.09 40.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.878 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.67 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 74.7 m -102.95 120.2 40.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.409 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 22' ' ' GLY . 28.2 mtm180 . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.78 158.81 28.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.3 p-10 -58.19 126.89 29.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.094 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.53 -7.47 57.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.195 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.74 139.5 22.99 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.846 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -80.87 127.6 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.989 0.423 . . . . 0.0 110.172 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 p -117.45 137.47 24.15 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.814 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.51 169.2 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.629 2.219 . . . . 0.0 111.57 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -46.63 108.39 0.84 Allowed Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 123.982 0.801 . . . . 0.0 111.953 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.57 -20.23 63.53 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.005 2.47 . . . . 0.0 112.854 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.74 -36.9 83.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.603 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -98.07 -45.99 6.04 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.552 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.0 -3.97 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.51 161.64 33.54 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.093 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -86.29 113.7 22.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -132.4 111.2 11.11 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.037 0.923 . . . . 0.0 110.021 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.9 t -162.31 161.11 27.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.13 103.39 15.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 161.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.05 -109.88 2.19 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.815 -170.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.72 140.62 27.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.79 111.82 23.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.476 0.655 . . . . 0.0 109.921 175.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.5 mt -124.45 121.57 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.024 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 59.74 44.68 13.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.195 0.521 . . . . 0.0 110.707 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.9 m120 63.63 18.86 11.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.663 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -119.82 142.28 48.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 19.8 t -101.31 119.26 38.49 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.307 -175.575 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.516 HG11 ' SG ' ' A' ' 20' ' ' CYS . 12.3 p . . . . . 0 C--O 1.225 -0.233 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.07 168.82 19.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -54.57 143.49 24.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.357 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.69 -10.15 65.88 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.995 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 146.99 45.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.751 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.618 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 27.2 t80 -91.0 125.93 35.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -123.43 137.97 29.36 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.302 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.21 157.48 39.74 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.407 2.071 . . . . 0.0 111.421 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.78 113.01 2.69 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.452 -172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.91 -25.22 51.81 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.469 2.779 . . . . 0.0 112.875 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.64 -39.33 91.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -97.41 -45.44 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.542 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -105.45 1.58 27.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.41 155.24 16.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.975 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.91 117.56 20.11 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.319 0.248 . . . . 0.0 110.546 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -138.41 113.05 8.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.104 0.954 . . . . 0.0 111.078 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.516 ' SG ' HG11 ' A' ' 4' ' ' VAL . 39.9 t -162.03 173.14 14.82 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.166 168.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 3.8 m -86.96 102.06 14.02 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 161.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.24 -121.82 5.25 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.34 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -137.0 137.08 39.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.041 0.421 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -98.18 112.11 24.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.52 125.5 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.826 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 63.91 38.89 8.55 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.121 0.263 . . . . 0.0 111.004 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 m120 65.27 11.84 7.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.386 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -133.53 158.54 42.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.5 t -101.59 135.94 42.26 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.025 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.062 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.41 HG11 ' SG ' ' A' ' 20' ' ' CYS . 9.0 p . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 178.73 6.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.024 -173.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 6.7 m-20 -52.86 138.06 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.014 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.71 -9.27 71.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.568 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.41 135.11 49.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.111 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' A' ' 9' ' ' PHE . 72.8 t80 -92.16 111.41 22.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -111.38 137.92 21.22 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 29.5 Cg_endo -61.12 163.53 16.62 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.314 2.009 . . . . 0.0 110.956 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.55 111.42 2.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.881 0.738 . . . . 0.0 111.232 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.24 -21.99 38.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.253 2.635 . . . . 0.0 113.262 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.2 -34.03 59.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 75.5 mmtt -97.06 -45.96 6.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.2 mpt? -98.2 -31.32 12.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.618 0.247 . . . . 0.0 111.561 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.76 156.18 9.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.9 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.82 106.52 18.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -129.4 111.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.756 0.789 . . . . 0.0 111.259 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.41 ' SG ' HG11 ' A' ' 4' ' ' VAL . 7.8 t -163.58 173.78 12.58 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.518 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.78 104.74 16.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 159.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.68 -136.12 9.55 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -127.47 139.13 53.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.128 0.464 . . . . 0.0 110.752 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -97.92 110.89 23.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.36 115.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.815 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 61.76 44.53 8.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.446 0.466 . . . . 0.0 110.842 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.98 24.51 13.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.292 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 34.9 mt-10 -125.0 152.33 44.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.198 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.2 m -102.34 119.92 39.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.829 -179.223 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.466 HG11 ' SG ' ' A' ' 20' ' ' CYS . 10.9 p . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.71 174.68 6.11 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.634 0.254 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -55.55 135.84 50.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.203 0.525 . . . . 0.0 111.109 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.19 -6.31 72.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 158.96 45.51 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.871 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 90.0 t80 -90.56 133.48 35.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.8 p -139.59 142.33 31.35 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.24 160.41 26.9 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.376 2.051 . . . . 0.0 111.075 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.12 110.5 1.81 Allowed Pre-proline 0 C--N 1.327 -0.4 0 O-C-N 124.006 0.816 . . . . 0.0 111.557 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.66 -24.73 64.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.098 2.532 . . . . 0.0 112.178 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.94 -40.78 85.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.545 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.45 -46.67 5.68 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -178.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.499 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.3 mpt? -96.28 1.15 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.86 156.9 24.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.398 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.48 108.53 17.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.743 0.306 . . . . 0.0 110.705 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -127.39 113.42 16.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.583 0.706 . . . . 0.0 110.251 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' HG11 ' A' ' 4' ' ' VAL . 44.7 t -161.85 173.28 14.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.367 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 33.2 m -93.45 103.44 15.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 155.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.21 -128.46 7.99 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -166.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -141.62 134.87 29.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.303 0.551 . . . . 0.0 111.129 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -97.61 114.4 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.311 0.577 . . . . 0.0 110.004 177.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -131.68 116.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.94 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 64.12 44.75 4.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 111.477 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 22.3 m120 74.66 0.82 3.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.349 173.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.35 158.4 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 53.8 t -102.87 145.09 30.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.598 0.713 . . . . 0.0 111.783 -175.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.929 -178.416 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.547 HG11 ' SG ' ' A' ' 20' ' ' CYS . 12.2 p . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.62 177.75 5.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -52.58 138.71 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.37 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.585 ' HA2' ' OE2' ' A' ' 28' ' ' GLU . . . 86.69 0.85 85.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.357 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 146.44 21.14 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.172 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 1.638 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 74.2 t80 -85.35 120.96 27.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.437 . . . . 0.0 110.199 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 p -119.38 138.04 26.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.24 164.06 15.74 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.633 2.222 . . . . 0.0 111.526 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.574 ' OD1' ' HG2' ' A' ' 14' ' ' GLU . 8.9 t70 -52.74 127.28 42.91 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.671 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.92 -17.87 39.47 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.426 2.751 . . . . 0.0 114.139 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.574 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 6.6 pt-20 -77.41 -31.19 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.808 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 37.6 mmtm -97.73 -42.86 7.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -113.49 6.35 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.713 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.8 167.45 14.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.905 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -81.84 103.66 11.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -124.14 111.49 15.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.705 0.764 . . . . 0.0 110.624 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.547 ' SG ' HG11 ' A' ' 4' ' ' VAL . 22.9 t -164.01 174.36 11.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.874 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.05 102.43 14.49 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 155.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.34 -128.8 6.71 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.047 -170.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 9.6 mmt180 -141.12 137.64 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.107 0.453 . . . . 0.0 111.372 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.48 111.69 23.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 110.617 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.91 117.64 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.68 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 62.5 46.31 5.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.96 0.409 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 m120 61.65 18.27 9.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.905 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' OE2' ' HA2' ' A' ' 7' ' ' GLY . 46.4 tp10 -131.38 142.34 50.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 54.1 t -102.77 136.06 43.29 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.046 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.772 -178.115 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -97.88 136.51 38.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.005 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.45 151.21 25.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.287 0.565 . . . . 0.0 110.99 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.15 146.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.991 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.75 165.89 23.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.52 135.95 57.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.092 0.472 . . . . 0.0 111.502 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.09 -6.54 82.6 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.013 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.24 163.38 54.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.453 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.0 129.56 44.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.659 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.13 122.64 26.86 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.528 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HD2' ' NE1' ' A' ' 19' ' ' TRP . 32.0 Cg_endo -62.04 169.05 8.08 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.863 2.375 . . . . 0.0 112.375 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.08 111.23 1.01 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 123.988 0.805 . . . . 0.0 112.512 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 54.0 Cg_exo -55.63 -27.87 62.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.374 2.716 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -71.2 -36.83 72.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.18 -46.19 5.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.12 -16.69 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.289 . . . . 0.0 111.582 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 154.92 31.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.516 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 13' ' ' PRO . 4.7 p-10 -88.74 130.27 35.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.081 0.467 . . . . 0.0 110.43 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.458 ' NE1' ' HD2' ' A' ' 11' ' ' PRO . 1.6 p-90 -143.2 113.57 7.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.773 0.797 . . . . 0.0 109.965 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.0 t -161.21 154.77 21.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.709 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.74 103.07 15.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 164.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 -105.09 1.13 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.067 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -144.33 144.71 31.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.673 0.236 . . . . 0.0 110.575 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 t -96.71 110.11 22.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.7 mt -130.06 122.61 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.91 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 59.34 40.06 21.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 110.663 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.0 m120 62.57 22.78 13.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.461 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.04 152.29 42.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.26 119.7 39.15 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.4 137.06 51.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.801 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -134.01 144.18 48.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.786 176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.221 -178.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -84.32 145.0 28.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.28 -177.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.6 m -135.26 168.93 18.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.1 p -92.84 145.78 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -79.51 166.42 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.15 0.5 . . . . 0.0 111.544 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 21.2 t30 -59.76 125.33 23.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.622 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.18 -7.57 52.13 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.341 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.84 156.06 51.47 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.201 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 58.8 t80 -97.68 122.53 40.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.761 0.315 . . . . 0.0 110.431 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 7.9 p -118.01 130.69 24.57 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 34.6 Cg_endo -62.98 166.65 13.77 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.28 1.987 . . . . 0.0 110.798 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -44.36 109.55 0.87 Allowed Pre-proline 0 C--N 1.329 -0.304 0 O-C-N 124.016 0.822 . . . . 0.0 111.281 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.14 -29.67 89.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.163 2.575 . . . . 0.0 113.76 -171.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.49 -24.86 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.414 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -97.08 -45.21 6.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.5 mtt -110.47 3.76 19.89 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.88 142.47 13.16 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.543 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.1 117.58 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.505 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 5.9 p-90 -134.2 112.33 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.815 0.817 . . . . 0.0 110.549 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 42.9 t -161.07 159.46 29.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.115 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 103.81 14.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 163.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.92 -111.62 2.24 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.235 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -144.67 142.85 30.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.908 0.354 . . . . 0.0 110.819 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -98.71 111.51 23.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.251 176.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.73 114.16 46.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.037 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.72 56.75 6.37 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.503 0.502 . . . . 0.0 111.361 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 23.9 m120 66.64 19.01 10.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.424 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 36.1 tt0 -129.13 145.38 51.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 36.6 t -100.75 128.14 46.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -127.34 138.47 53.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.17 144.14 46.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.141 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.197 -1.335 . . . . 0.0 111.077 -178.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -79.61 142.25 35.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 15.0 p 56.98 150.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.0 113.294 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.698 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 t -92.63 133.38 34.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.751 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.32 163.93 21.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p-10 -61.92 133.71 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.276 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.21 4.26 84.08 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.03 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.62 153.66 24.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.951 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.56 121.75 29.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.826 0.346 . . . . 0.0 110.813 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -109.0 126.93 28.25 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.61 167.9 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.479 2.119 . . . . 0.0 111.525 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.07 107.17 0.5 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 124.167 0.917 . . . . 0.0 112.889 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.93 -26.42 74.46 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.168 2.579 . . . . 0.0 112.371 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 15' ' ' LYS . 7.0 pt-20 -57.07 -42.85 81.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.736 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 47.1 mmtm -98.82 -46.4 5.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -94.0 -5.24 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.02 155.62 26.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.066 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -78.31 96.73 5.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -125.63 112.28 15.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.161 0.981 . . . . 0.0 110.817 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 67.2 m -158.67 167.04 30.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.544 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -84.47 104.38 14.43 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 165.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -105.57 2.19 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -171.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -140.54 148.52 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.762 -0.258 . . . . 0.0 111.276 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.459 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 40.1 t -97.6 109.72 22.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.8 mt -128.8 110.64 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.377 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 63.37 39.94 8.91 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.42 0.45 . . . . 0.0 110.352 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.64 24.74 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.12 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -125.66 144.57 50.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.698 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 90.6 m -101.09 121.92 42.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.918 0.39 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -120.89 141.05 50.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.167 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -120.97 132.07 54.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.824 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.796 0 CA-C-O 118.729 -1.04 . . . . 0.0 112.045 -179.096 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.952 0.406 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.29 158.11 15.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.13 143.89 40.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.573 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.679 HG11 ' SG ' ' A' ' 20' ' ' CYS . 4.2 p -86.86 120.61 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.294 0.569 . . . . 0.0 109.679 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.13 -170.32 3.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.546 -170.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 25.7 p-10 -50.73 138.89 17.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.471 0.653 . . . . 0.0 111.885 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.5 71.67 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.787 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.33 153.07 49.02 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.148 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' A' ' 9' ' ' PHE . 81.6 t80 -99.05 131.07 45.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.236 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.7 p -132.94 143.24 47.76 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.82 164.97 27.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.28 1.986 . . . . 0.0 111.171 173.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 3.0 p-10 -52.53 112.51 3.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.718 0.636 . . . . 0.0 111.613 -177.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.5 Cg_exo -59.29 -21.51 60.76 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.492 2.794 . . . . 0.0 113.203 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 10.6 pt-20 -65.04 -40.57 95.0 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.124 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.3 mptm? -96.91 -45.92 6.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.05 0.23 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.78 161.76 23.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.949 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -89.48 114.16 25.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -137.55 109.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.523 0.678 . . . . 0.0 110.552 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.679 ' SG ' HG11 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -164.87 174.37 10.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.08 172.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.38 104.99 14.87 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 162.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 -127.64 8.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -131.98 141.36 49.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 14.6 t -96.6 112.53 24.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.8 106.12 17.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.217 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 54.42 55.39 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.351 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.8 m120 72.16 5.52 5.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.188 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.6 143.77 50.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 73.0 m -103.08 134.3 46.74 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.107 0.48 . . . . 0.0 111.588 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -118.23 143.85 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.094 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.73 140.52 42.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.473 -1.182 . . . . 0.0 111.838 -177.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.279 0.562 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -145.12 164.03 32.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.16 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.568 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 24.6 p -71.44 157.99 37.07 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.717 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 31.9 t -83.28 124.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -69.51 163.65 24.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.613 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -53.0 131.84 36.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.058 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.12 83.27 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.185 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 169.9 54.66 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.516 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -97.98 134.37 41.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.912 0.387 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -124.87 130.69 24.14 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.539 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.35 164.31 23.52 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.389 2.059 . . . . 0.0 111.092 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 56.5 m-20 -48.67 112.28 2.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 O-C-N 123.856 0.722 . . . . 0.0 112.016 -173.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 -27.3 52.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.348 2.699 . . . . 0.0 112.937 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.8 pt-20 -62.2 -40.69 96.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 5.3 tppp? -98.81 -46.22 5.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.3 mpt? -101.31 3.03 40.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.36 159.36 25.5 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.434 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 24' ' ' CYS . 12.0 t70 -86.83 106.95 18.08 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.29 111.0 9.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.627 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 33.2 m -160.06 163.17 34.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.847 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 33.7 m -83.78 105.61 14.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 166.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.93 -102.63 1.89 Allowed Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -143.96 149.58 36.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.989 0.116 . . . . 0.0 110.722 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 36.2 t -97.45 110.32 22.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -128.28 111.59 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.211 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 59.81 48.91 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.23 24.56 14.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.008 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -133.19 150.74 51.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.824 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.717 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 81.5 m -100.74 119.04 38.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 30' ' ' ARG . 20.7 mtp180 -117.02 138.88 51.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.555 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -150.84 135.38 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.553 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.322 -1.265 . . . . 0.0 111.447 -178.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 121.177 0.513 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.2 pm0 -92.6 158.64 15.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.228 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.4 p -119.73 147.08 45.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.97 0.414 . . . . 0.0 110.259 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 13.9 p -90.12 147.46 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.81 171.91 11.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 111.25 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -56.79 133.5 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.573 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -14.21 65.41 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.632 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.16 139.99 38.94 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.176 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.633 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 88.9 t80 -82.78 119.21 24.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.045 0.45 . . . . 0.0 110.245 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -115.54 127.03 27.13 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.759 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 26.5 Cg_endo -60.58 160.03 25.78 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.507 2.138 . . . . 0.0 111.166 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 6.2 m-20 -45.07 108.11 0.72 Allowed Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 124.357 1.036 . . . . 0.0 112.423 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -54.34 -29.08 56.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.384 2.723 . . . . 0.0 112.947 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.5 pt-20 -58.62 -38.64 78.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.93 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 24.3 tptm -99.1 -46.16 5.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.4 mpt? -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.25 146.12 5.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.492 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.55 110.01 9.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.512 ' CZ3' ' HB ' ' A' ' 4' ' ' VAL . 14.8 p-90 -128.6 112.05 13.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.109 0.956 . . . . 0.0 110.02 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.7 t -162.46 154.53 18.78 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.864 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.57 101.96 12.51 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 163.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -109.68 2.06 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.744 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.86 140.07 28.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -95.8 110.29 22.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.11 122.93 62.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.036 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 2.9 mmp_? 58.11 41.08 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.417 0.448 . . . . 0.0 110.358 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 66.66 19.36 10.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.131 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.21 151.98 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.7 t -100.48 123.42 44.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 109.909 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -127.95 146.96 50.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.167 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -116.72 151.13 37.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.942 178.39 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.918 0.39 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -117.95 147.69 42.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 10.2 p -99.37 151.66 20.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.408 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 8.8 p -84.18 148.34 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.934 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.82 166.12 20.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.0 111.13 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -61.33 136.45 58.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.545 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.43 78.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.067 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.49 162.84 54.25 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.397 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 79.7 t80 -95.88 136.44 36.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.46 . . . . 0.0 110.892 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -132.24 150.87 77.19 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 18.2 Cg_endo -58.88 170.47 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.374 2.049 . . . . 0.0 111.592 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.611 ' OD1' ' HD3' ' A' ' 15' ' ' LYS . 9.0 t70 -46.22 109.05 0.91 Allowed Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.837 0.71 . . . . 0.0 111.427 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.45 -24.42 68.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.418 2.745 . . . . 0.0 113.887 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.65 -43.82 16.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.717 0.294 . . . . 0.0 110.93 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' HD3' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -86.74 -45.32 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.185 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -92.78 -22.69 19.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.5 149.48 23.54 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.508 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.96 120.14 27.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.185 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.43 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 42.1 p-90 -125.25 113.18 17.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.767 0.794 . . . . 0.0 110.606 175.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.45 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 47.0 t -160.83 173.53 15.22 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.267 173.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 55.0 m -88.31 103.72 16.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 161.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.11 -117.51 3.67 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.76 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -144.94 135.57 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.854 0.327 . . . . 0.0 111.232 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -103.65 118.1 35.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.272 0.558 . . . . 0.0 109.725 175.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -136.32 130.23 47.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.213 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 65.76 36.64 6.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.556 0.342 . . . . 0.0 111.002 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 21.3 m120 64.5 15.93 9.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -132.94 149.71 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -101.74 134.99 44.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.706 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -120.99 151.36 39.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.783 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.53 106.41 12.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.737 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.504 -1.164 . . . . 0.0 111.515 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.656 0.265 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 11.8 pt-20 -82.09 167.76 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 7.7 p 52.9 172.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 113.047 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.642 HG11 ' SG ' ' A' ' 20' ' ' CYS . 9.3 p -87.37 145.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.008 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -75.31 165.84 24.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.159 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -59.99 145.3 46.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.39 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.02 -11.24 67.73 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.641 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.28 142.3 40.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.816 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -84.34 131.94 34.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.5 p -136.01 142.52 40.56 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.71 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.04 158.4 43.88 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.349 2.033 . . . . 0.0 111.01 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.45 118.5 19.18 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.59 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.68 -28.74 48.11 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.702 2.935 . . . . 0.0 113.437 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -96.6 -45.85 6.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.4 mmm -110.56 0.68 17.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.64 30.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.214 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.468 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 22.7 t70 -86.95 114.59 23.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.629 0.252 . . . . 0.0 110.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -134.76 112.15 10.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.975 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.642 ' SG ' HG11 ' A' ' 4' ' ' VAL . 16.4 t -164.11 174.91 10.73 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.604 169.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 17.2 m -84.19 103.09 13.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.09 -117.14 4.32 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -144.77 140.67 28.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.951 0.375 . . . . 0.0 111.082 -178.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.7 t -98.24 117.32 32.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.42 122.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.989 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 61.49 41.51 12.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.076 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.9 m120 67.34 7.88 5.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.255 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -128.56 148.55 50.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -102.5 147.11 27.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.317 0.58 . . . . 0.0 111.845 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.09 149.31 52.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -125.82 142.78 51.35 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.026 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.232 -179.389 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -145.48 119.06 9.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.9 p -112.44 148.95 33.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.043 0.449 . . . . 0.0 110.267 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -85.38 145.99 7.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.62 164.67 26.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.169 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 95.0 m-20 -59.27 133.11 55.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.235 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.75 -12.17 66.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.5 156.2 46.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.448 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' A' ' 9' ' ' PHE . 79.4 t80 -93.44 121.32 34.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.666 0.27 . . . . 0.0 110.869 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 4.3 p -129.07 126.66 23.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.915 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.49 172.09 7.18 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.725 2.284 . . . . 0.0 112.272 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 9.6 p-10 -55.56 121.51 39.09 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.401 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.23 -26.38 51.47 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.713 2.942 . . . . 0.0 113.671 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' C ' ' HE3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -68.3 -31.96 71.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -96.56 -45.47 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.584 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mpt? -114.48 0.61 14.08 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.3 152.91 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.69 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.81 119.93 30.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.206 0.527 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -122.74 112.15 17.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.673 0.749 . . . . 0.0 109.743 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.4 t -162.5 155.96 20.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.747 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.99 102.44 14.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 -109.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.127 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -139.28 146.15 40.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.292 . . . . 0.0 110.799 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.45 110.99 23.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 28.6 mt -136.14 127.49 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.965 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 25' ' ' ILE . 15.6 mtm180 62.65 33.44 15.66 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.62 0.368 . . . . 0.0 110.862 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 18.6 m120 61.97 20.65 11.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 110.811 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 32.5 mt-10 -116.38 156.23 27.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 38.4 t -102.66 119.68 39.25 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -132.46 151.83 51.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -98.0 142.21 30.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.592 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.334 -1.259 . . . . 0.0 111.265 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.058 0.456 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -104.46 156.97 17.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.047 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.8 p -136.95 170.66 15.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.848 0.356 . . . . 0.0 110.446 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 ' HB ' ' SG ' ' A' ' 20' ' ' CYS . 47.3 t -77.9 147.05 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.112 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -87.68 166.42 14.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.741 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -57.25 133.97 55.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.27 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -3.11 76.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.249 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.57 148.61 49.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.011 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.64 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 55.8 t80 -89.44 130.55 35.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.786 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.7 p -124.72 147.5 56.28 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.31 170.67 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.217 1.945 . . . . 0.0 111.568 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.79 112.59 2.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.057 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 -27.23 67.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.086 2.524 . . . . 0.0 112.499 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -67.45 -33.08 74.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.114 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.65 -45.62 6.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -102.23 -14.71 16.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 155.87 25.99 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -171.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' HB2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -86.3 123.55 31.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -129.53 112.46 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.555 0.693 . . . . 0.0 110.357 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 28.9 t -162.21 175.04 12.08 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.593 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.2 m -84.63 105.27 15.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 160.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.97 7.99 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -135.7 134.01 38.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -99.07 112.16 24.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 109.691 176.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.7 mt -120.13 120.55 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.892 -174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 57.08 50.38 12.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.366 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 65.3 13.28 8.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.213 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.33 147.57 52.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.8 t -102.14 137.44 40.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.406 0.622 . . . . 0.0 112.255 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -131.1 147.25 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.722 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -129.06 151.54 49.63 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.529 -1.151 . . . . 0.0 111.867 -179.238 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.804 0.335 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.76 156.79 21.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.444 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.7 p -99.84 163.2 12.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.916 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.8 t -91.49 146.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.352 -178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.97 158.43 35.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.148 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -60.48 124.45 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.79 -10.14 58.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.264 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.68 152.23 52.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.384 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 48.9 t80 -92.28 128.11 38.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 0.0 110.563 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.2 p -121.38 133.4 24.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.339 -0.392 . . . . 0.0 109.991 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.58 167.88 14.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 111.939 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -42.66 109.25 0.72 Allowed Pre-proline 0 C--O 1.237 0.423 0 O-C-N 124.263 0.977 . . . . 0.0 112.613 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.86 -18.62 42.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.344 2.696 . . . . 0.0 112.641 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -62.56 -39.16 92.78 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -97.54 -45.44 6.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.75 -175.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.0 mtt -108.22 8.04 27.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.75 162.24 5.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.786 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -86.33 121.85 29.48 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -124.89 112.89 17.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.865 0.84 . . . . 0.0 109.589 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 35.5 t -160.55 163.22 32.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.654 -173.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -92.63 103.55 15.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 161.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.3 -109.97 2.4 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.023 -170.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -139.83 138.71 36.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 110.782 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -98.93 111.17 23.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 109.963 176.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.14 129.82 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.986 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 58.82 43.28 18.57 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.398 0.436 . . . . 0.0 111.006 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 28.8 m120 60.61 26.27 15.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.304 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -131.37 150.8 52.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -100.73 119.55 38.78 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -125.04 144.63 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.805 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.13 147.16 33.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.652 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.467 -1.185 . . . . 0.0 111.895 -178.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.757 0.313 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.34 136.13 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 110.503 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -88.04 141.77 28.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.858 0.361 . . . . 0.0 110.083 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.22 121.62 33.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.796 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.8 -175.06 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.25 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 2.3 p-10 -51.53 132.6 30.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.333 0.587 . . . . 0.0 111.268 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.16 13.33 17.93 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.301 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.32 141.6 15.37 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.606 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 60.4 t80 -93.94 111.95 23.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.9 p -114.95 123.26 32.18 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.986 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.476 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 84.6 Cg_exo -53.94 164.43 2.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.915 2.41 . . . . 0.0 112.287 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -37.6 114.91 0.74 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 124.29 0.994 . . . . 0.0 112.711 -171.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.583 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 44.6 Cg_exo -58.56 -42.33 55.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.333 2.689 . . . . 0.0 114.028 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -81.26 -37.06 29.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.601 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -96.14 -35.93 11.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.858 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 11' ' ' PRO . 64.4 mtt -103.87 -21.96 13.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.18 144.69 6.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.566 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 14.6 t70 -98.93 106.64 18.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.731 0.301 . . . . 0.0 110.459 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.476 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 30.6 p-90 -132.06 112.19 12.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.692 0.758 . . . . 0.0 110.208 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.09 173.19 16.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.667 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 t -84.5 105.35 15.25 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.23 1.73 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.832 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 1.1 tmt_? -144.67 146.85 32.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 34.6 t -97.31 113.06 24.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.9 mt -126.6 117.71 48.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.0 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 59.46 43.42 16.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 110.65 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 20.0 m120 62.93 26.72 15.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.398 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -133.02 153.35 51.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.599 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 90.5 m -101.81 124.99 48.37 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.207 0.527 . . . . 0.0 110.629 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -106.39 113.85 27.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.733 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.65 97.21 7.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.675 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.284 -1.287 . . . . 0.0 111.308 -177.173 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.89 0.376 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.77 143.29 28.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 110.255 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.498 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 31.6 p -118.81 158.14 26.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.865 0.364 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.565 HG11 ' SG ' ' A' ' 29' ' ' CYS . 4.1 p -104.73 129.04 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.51 171.84 9.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.202 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 5.2 p-10 -52.62 137.96 29.47 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.486 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.69 69.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.742 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.71 150.57 28.25 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.172 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 27' ' ' ASN . 78.6 t80 -89.92 122.77 33.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -109.81 132.33 21.44 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.06 166.16 17.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.443 2.096 . . . . 0.0 111.508 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 14' ' ' GLU . 21.1 t70 -45.46 113.08 1.8 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.049 0.843 . . . . 0.0 111.87 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.2 Cg_exo -59.45 -20.96 59.21 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.211 2.607 . . . . 0.0 113.326 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 34.9 mm-40 -74.98 -33.58 61.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.521 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -96.34 -45.28 6.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.349 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.15 -8.36 25.26 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 163.87 38.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.876 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.08 107.12 13.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -135.86 112.41 10.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.072 0.939 . . . . 0.0 111.035 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.498 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 88.6 m -158.96 166.7 31.2 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.9 m -84.9 103.76 14.25 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 162.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.89 -117.67 4.22 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.72 149.48 49.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.716 0.258 . . . . 0.0 110.598 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.433 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 42.9 t -97.84 109.46 22.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.85 111.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.975 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 61.65 44.69 8.69 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.42 0.45 . . . . 0.0 110.881 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 22.3 m120 62.77 28.21 16.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.396 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -132.17 144.29 50.57 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' HG11 ' A' ' 4' ' ' VAL . 92.4 m -101.25 119.0 38.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -123.09 143.94 49.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.056 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -134.87 142.46 46.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -1.32 . . . . 0.0 111.235 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.6 119.1 16.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.979 0.419 . . . . 0.0 110.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -88.41 140.15 29.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.921 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 20' ' ' CYS . 6.6 p -76.21 130.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.0 167.15 20.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.325 -172.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.1 p-10 -59.26 137.21 58.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.201 0.524 . . . . 0.0 110.738 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.41 -13.39 56.9 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.533 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.46 150.31 49.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.365 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.75 124.87 39.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -116.78 134.65 22.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.984 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 30.4 Cg_endo -63.19 159.99 36.66 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 111.461 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.74 116.5 6.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.281 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.36 -28.9 55.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.538 2.825 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.93 -37.41 84.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.6 OUTLIER -97.04 -45.99 6.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 11' ' ' PRO . 2.3 mpt? -102.18 -14.41 17.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -172.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.91 167.63 36.19 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -88.71 107.3 18.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -133.35 112.18 11.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.829 0.823 . . . . 0.0 110.188 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.439 ' HA ' ' CG1' ' A' ' 4' ' ' VAL . 64.2 m -160.05 170.74 20.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.086 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.67 104.61 15.55 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 160.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.54 -113.03 3.84 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.21 -171.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -133.3 152.26 51.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.66 -0.318 . . . . 0.0 111.153 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -97.79 109.65 22.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 62.9 mt -129.16 115.92 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.248 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 60.66 40.45 16.44 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.183 0.302 . . . . 0.0 110.687 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.75 29.49 19.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.279 0.562 . . . . 0.0 110.844 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 25' ' ' ILE . 36.5 tt0 -132.61 145.57 51.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.293 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 93.6 m -100.71 122.73 43.84 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -126.11 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.902 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -107.13 161.02 15.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.14 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.893 -0.949 . . . . 0.0 111.29 179.812 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -88.24 135.86 33.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 0.0 110.159 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 p -94.25 156.33 16.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.91 0.386 . . . . 0.0 110.538 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.67 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 23.7 t -83.35 140.06 16.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.668 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.94 162.95 27.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.922 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 94.3 m-20 -63.28 126.98 29.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.961 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.09 -4.04 84.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.035 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.75 52.9 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.629 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 57.3 t80 -88.46 117.72 27.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 p -112.66 130.97 22.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.444 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.99 161.64 25.25 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.336 2.024 . . . . 0.0 111.136 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -51.07 123.11 18.88 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.761 0.663 . . . . 0.0 111.572 -172.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.06 -20.85 47.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.431 2.754 . . . . 0.0 114.028 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -80.84 -25.94 37.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.62 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -45.86 6.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -108.15 -10.32 15.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.12 166.42 35.57 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.818 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.5 109.12 20.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.894 0.378 . . . . 0.0 110.295 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -135.49 111.05 9.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.806 0.812 . . . . 0.0 110.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.5 m -160.75 173.63 15.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.733 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 106.02 18.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . 107.99 -106.79 2.43 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' HD2' ' C ' ' A' ' 22' ' ' GLY . 8.4 mpt_? -137.39 152.32 49.51 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.337 0.255 . . . . 0.0 110.387 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.6 t -96.92 110.2 22.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.93 120.46 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.2 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 60.07 32.8 21.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.646 0.378 . . . . 0.0 110.744 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 27.2 m120 66.13 23.49 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.853 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.82 151.09 40.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.878 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.67 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 74.7 m -102.95 120.2 40.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.409 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 22' ' ' GLY . 28.2 mtm180 -118.77 130.29 55.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -117.78 138.59 51.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.307 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.921 -0.933 . . . . 0.0 111.32 -178.874 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 120.741 0.305 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.86 136.64 33.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.413 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.1 p 52.67 -177.23 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.164 0.985 . . . . 0.0 112.652 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.36 143.6 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.78 158.81 28.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.3 p-10 -58.19 126.89 29.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.094 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.53 -7.47 57.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.195 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.74 139.5 22.99 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.846 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -80.87 127.6 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.989 0.423 . . . . 0.0 110.172 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 p -117.45 137.47 24.15 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.814 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.51 169.2 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.629 2.219 . . . . 0.0 111.57 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -46.63 108.39 0.84 Allowed Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 123.982 0.801 . . . . 0.0 111.953 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.57 -20.23 63.53 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.005 2.47 . . . . 0.0 112.854 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.74 -36.9 83.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.603 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -98.07 -45.99 6.04 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.552 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.0 -3.97 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.51 161.64 33.54 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.093 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -86.29 113.7 22.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -132.4 111.2 11.11 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.037 0.923 . . . . 0.0 110.021 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.9 t -162.31 161.11 27.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.13 103.39 15.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 161.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.05 -109.88 2.19 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.815 -170.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.72 140.62 27.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.79 111.82 23.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.476 0.655 . . . . 0.0 109.921 175.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.5 mt -124.45 121.57 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.024 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 59.74 44.68 13.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.195 0.521 . . . . 0.0 110.707 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.9 m120 63.63 18.86 11.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.663 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -119.82 142.28 48.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 19.8 t -101.31 119.26 38.49 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -113.8 128.55 56.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.307 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -115.53 106.47 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.627 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.932 -0.926 . . . . 0.0 111.43 177.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -64.89 140.34 58.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.505 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.535 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 24.9 p -115.36 151.78 34.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.345 0.593 . . . . 0.0 111.749 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.516 HG11 ' SG ' ' A' ' 20' ' ' CYS . 12.3 p -82.2 148.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.483 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.07 168.82 19.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -54.57 143.49 24.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.357 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.69 -10.15 65.88 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.995 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 146.99 45.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.751 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.618 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 27.2 t80 -91.0 125.93 35.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -123.43 137.97 29.36 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.302 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.21 157.48 39.74 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.407 2.071 . . . . 0.0 111.421 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.78 113.01 2.69 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.452 -172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.91 -25.22 51.81 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.469 2.779 . . . . 0.0 112.875 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.64 -39.33 91.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -97.41 -45.44 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.542 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -105.45 1.58 27.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.41 155.24 16.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.975 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.91 117.56 20.11 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.319 0.248 . . . . 0.0 110.546 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -138.41 113.05 8.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.104 0.954 . . . . 0.0 111.078 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.535 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 39.9 t -162.03 173.14 14.82 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.166 168.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.8 m -86.96 102.06 14.02 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 161.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.24 -121.82 5.25 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.34 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -137.0 137.08 39.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.041 0.421 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -98.18 112.11 24.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.52 125.5 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.826 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 63.91 38.89 8.55 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.121 0.263 . . . . 0.0 111.004 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 m120 65.27 11.84 7.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.386 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -133.53 158.54 42.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.5 t -101.59 135.94 42.26 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.025 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -116.8 150.6 38.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.062 -177.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -87.47 -15.84 36.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.172 0.511 . . . . 0.0 109.858 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.592 179.48 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.025 0.44 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.99 147.25 45.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.474 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.8 m -106.85 160.62 15.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.933 0.397 . . . . 0.0 110.948 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG11 ' SG ' ' A' ' 20' ' ' CYS . 9.0 p -79.54 136.77 22.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.459 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 178.73 6.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.024 -173.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 6.7 m-20 -52.86 138.06 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.014 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.71 -9.27 71.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.568 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.41 135.11 49.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.111 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' A' ' 9' ' ' PHE . 72.8 t80 -92.16 111.41 22.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 110.449 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -111.38 137.92 21.22 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 29.5 Cg_endo -61.12 163.53 16.62 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.314 2.009 . . . . 0.0 110.956 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.55 111.42 2.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.881 0.738 . . . . 0.0 111.232 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.24 -21.99 38.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.253 2.635 . . . . 0.0 113.262 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.2 -34.03 59.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 75.5 mmtt -97.06 -45.96 6.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.2 mpt? -98.2 -31.32 12.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.618 0.247 . . . . 0.0 111.561 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.76 156.18 9.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.9 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.82 106.52 18.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -129.4 111.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.756 0.789 . . . . 0.0 111.259 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.41 ' SG ' HG11 ' A' ' 4' ' ' VAL . 7.8 t -163.58 173.78 12.58 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.518 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.78 104.74 16.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 159.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.68 -136.12 9.55 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -127.47 139.13 53.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.128 0.464 . . . . 0.0 110.752 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -97.92 110.89 23.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.36 115.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.815 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mtp180 61.76 44.53 8.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.446 0.466 . . . . 0.0 110.842 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.98 24.51 13.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.292 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 34.9 mt-10 -125.0 152.33 44.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.198 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.2 m -102.34 119.92 39.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -131.0 111.56 12.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.829 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.28 70.29 2.73 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.604 -1.109 . . . . 0.0 111.452 -176.895 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.908 0.385 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -115.87 141.77 47.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.9 p -94.23 148.24 22.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.74 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.466 HG11 ' SG ' ' A' ' 20' ' ' CYS . 10.9 p -75.81 147.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.71 174.68 6.11 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.634 0.254 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -55.55 135.84 50.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.203 0.525 . . . . 0.0 111.109 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.19 -6.31 72.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 158.96 45.51 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.871 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' A' ' 9' ' ' PHE . 90.0 t80 -90.56 133.48 35.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.8 p -139.59 142.33 31.35 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.24 160.41 26.9 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.376 2.051 . . . . 0.0 111.075 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.12 110.5 1.81 Allowed Pre-proline 0 C--N 1.327 -0.4 0 O-C-N 124.006 0.816 . . . . 0.0 111.557 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.66 -24.73 64.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.098 2.532 . . . . 0.0 112.178 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.94 -40.78 85.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.545 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.45 -46.67 5.68 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -178.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.499 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.3 mpt? -96.28 1.15 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.86 156.9 24.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.398 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.48 108.53 17.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.743 0.306 . . . . 0.0 110.705 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -127.39 113.42 16.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.583 0.706 . . . . 0.0 110.251 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.466 ' SG ' HG11 ' A' ' 4' ' ' VAL . 44.7 t -161.85 173.28 14.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.367 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 33.2 m -93.45 103.44 15.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 155.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.21 -128.46 7.99 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -166.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -141.62 134.87 29.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.303 0.551 . . . . 0.0 111.129 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -97.61 114.4 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.311 0.577 . . . . 0.0 110.004 177.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -131.68 116.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.94 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 64.12 44.75 4.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 111.477 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 22.3 m120 74.66 0.82 3.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.349 173.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.35 158.4 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 53.8 t -102.87 145.09 30.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.598 0.713 . . . . 0.0 111.783 -175.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -128.1 147.28 50.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.929 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -144.2 153.01 41.64 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.706 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.915 -1.492 . . . . 0.0 111.02 178.428 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.771 0.32 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.24 134.69 50.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.188 0.518 . . . . 0.0 110.48 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 p -111.04 153.04 26.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.547 HG11 ' SG ' ' A' ' 20' ' ' CYS . 12.2 p -79.79 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.62 177.75 5.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -52.58 138.71 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.37 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.585 ' HA2' ' OE2' ' A' ' 28' ' ' GLU . . . 86.69 0.85 85.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.357 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 146.44 21.14 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.172 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 1.638 ' HD1' ' CD2' ' A' ' 9' ' ' PHE . 74.2 t80 -85.35 120.96 27.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.437 . . . . 0.0 110.199 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 p -119.38 138.04 26.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.24 164.06 15.74 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.633 2.222 . . . . 0.0 111.526 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.574 ' OD1' ' HG2' ' A' ' 14' ' ' GLU . 8.9 t70 -52.74 127.28 42.91 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.671 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.92 -17.87 39.47 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.426 2.751 . . . . 0.0 114.139 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.574 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 6.6 pt-20 -77.41 -31.19 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.808 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 37.6 mmtm -97.73 -42.86 7.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -113.49 6.35 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.713 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.8 167.45 14.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.905 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -81.84 103.66 11.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -124.14 111.49 15.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.705 0.764 . . . . 0.0 110.624 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.547 ' SG ' HG11 ' A' ' 4' ' ' VAL . 22.9 t -164.01 174.36 11.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.874 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.05 102.43 14.49 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 155.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.34 -128.8 6.71 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.047 -170.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 9.6 mmt180 -141.12 137.64 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.107 0.453 . . . . 0.0 111.372 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.48 111.69 23.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 110.617 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.91 117.64 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.68 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 62.5 46.31 5.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.96 0.409 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 m120 61.65 18.27 9.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.905 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' OE2' ' HA2' ' A' ' 7' ' ' GLY . 46.4 tp10 -131.38 142.34 50.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 54.1 t -102.77 136.06 43.29 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.046 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -140.16 -179.61 6.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.772 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -130.39 163.24 27.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.399 177.195 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.75 165.89 23.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.52 135.95 57.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.092 0.472 . . . . 0.0 111.502 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.09 -6.54 82.6 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.013 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.24 163.38 54.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.453 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.0 129.56 44.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.659 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.13 122.64 26.86 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.528 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD2' ' NE1' ' A' ' 19' ' ' TRP . 32.0 Cg_endo -62.04 169.05 8.08 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.863 2.375 . . . . 0.0 112.375 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.08 111.23 1.01 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 123.988 0.805 . . . . 0.0 112.512 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 54.0 Cg_exo -55.63 -27.87 62.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.374 2.716 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -71.2 -36.83 72.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.18 -46.19 5.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.12 -16.69 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.289 . . . . 0.0 111.582 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 154.92 31.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.516 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 13' ' ' PRO . 4.7 p-10 -88.74 130.27 35.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.081 0.467 . . . . 0.0 110.43 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.447 ' NE1' ' HD2' ' A' ' 11' ' ' PRO . 1.6 p-90 -143.2 113.57 7.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.773 0.797 . . . . 0.0 109.965 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.0 t -161.21 154.77 21.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.709 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.74 103.07 15.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 164.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 -105.09 1.13 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.067 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -144.33 144.71 31.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.673 0.236 . . . . 0.0 110.575 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 t -96.71 110.11 22.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.7 mt -130.06 122.61 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.91 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 59.34 40.06 21.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 110.663 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.0 m120 62.57 22.78 13.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.461 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.04 152.29 42.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.26 119.7 39.15 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.801 -174.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 20' ' ' CYS . 14.1 p . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -79.51 166.42 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.15 0.5 . . . . 0.0 111.544 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 21.2 t30 -59.76 125.33 23.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.622 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.18 -7.57 52.13 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.341 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.84 156.06 51.47 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.201 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -97.68 122.53 40.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.761 0.315 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 7.9 p -118.01 130.69 24.57 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 34.6 Cg_endo -62.98 166.65 13.77 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.28 1.987 . . . . 0.0 110.798 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.9 t70 -44.36 109.55 0.87 Allowed Pre-proline 0 C--N 1.329 -0.304 0 O-C-N 124.016 0.822 . . . . 0.0 111.281 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 31.6 Cg_exo -60.14 -29.67 89.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.163 2.575 . . . . 0.0 113.76 -171.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.49 -24.86 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.414 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -97.08 -45.21 6.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.5 mtt -110.47 3.76 19.89 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.88 142.47 13.16 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.543 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.1 117.58 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.524 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 5.9 p-90 -134.2 112.33 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.815 0.817 . . . . 0.0 110.549 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 42.9 t -161.07 159.46 29.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.115 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 103.81 14.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 163.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.92 -111.62 2.24 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.235 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -144.67 142.85 30.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.908 0.354 . . . . 0.0 110.819 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -98.71 111.51 23.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.251 176.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 25' ' ' ILE . 3.3 mp -112.73 114.16 46.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.037 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.72 56.75 6.37 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.503 0.502 . . . . 0.0 111.361 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 23.9 m120 66.64 19.01 10.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.424 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 36.1 tt0 -129.13 145.38 51.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 36.6 t -100.75 128.14 46.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 -177.762 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.702 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 t . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.32 163.93 21.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p-10 -61.92 133.71 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.276 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.21 4.26 84.08 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.03 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.62 153.66 24.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.951 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.56 121.75 29.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.826 0.346 . . . . 0.0 110.813 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -109.0 126.93 28.25 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.61 167.9 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.479 2.119 . . . . 0.0 111.525 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 4.2 m-20 -42.07 107.17 0.5 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 124.167 0.917 . . . . 0.0 112.889 -175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 48.1 Cg_exo -57.93 -26.42 74.46 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.168 2.579 . . . . 0.0 112.371 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 15' ' ' LYS . 7.0 pt-20 -57.07 -42.85 81.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.736 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 47.1 mmtm -98.82 -46.4 5.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -94.0 -5.24 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.02 155.62 26.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.066 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 12.6 t70 -78.31 96.73 5.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -125.63 112.28 15.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.161 0.981 . . . . 0.0 110.817 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 67.2 m -158.67 167.04 30.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.544 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -84.47 104.38 14.43 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 165.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -105.57 2.19 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -171.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -140.54 148.52 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.762 -0.258 . . . . 0.0 111.276 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 40.1 t -97.6 109.72 22.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.8 mt -128.8 110.64 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.377 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 63.37 39.94 8.91 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.42 0.45 . . . . 0.0 110.352 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.64 24.74 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.12 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -125.66 144.57 50.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 90.6 m -101.09 121.92 42.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.918 0.39 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.167 -179.18 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.744 HG13 ' SG ' ' A' ' 20' ' ' CYS . 4.2 p . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.294 0.569 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.13 -170.32 3.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.546 -170.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 25.7 p-10 -50.73 138.89 17.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.471 0.653 . . . . 0.0 111.885 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.5 71.67 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.787 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.33 153.07 49.02 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.148 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -99.05 131.07 45.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.236 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.7 p -132.94 143.24 47.76 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.82 164.97 27.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.28 1.986 . . . . 0.0 111.171 173.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 3.0 p-10 -52.53 112.51 3.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.718 0.636 . . . . 0.0 111.613 -177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.5 Cg_exo -59.29 -21.51 60.76 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.492 2.794 . . . . 0.0 113.203 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 10.6 pt-20 -65.04 -40.57 95.0 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.124 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.3 mptm? -96.91 -45.92 6.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.05 0.23 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.78 161.76 23.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.949 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 13.3 t70 -89.48 114.16 25.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -137.55 109.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.523 0.678 . . . . 0.0 110.552 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.744 ' SG ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -164.87 174.37 10.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.08 172.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.38 104.99 14.87 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 162.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 -127.64 8.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -131.98 141.36 49.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 14.6 t -96.6 112.53 24.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.8 106.12 17.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.217 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 54.42 55.39 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.351 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.8 m120 72.16 5.52 5.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.188 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.6 143.77 50.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 73.0 m -103.08 134.3 46.74 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.107 0.48 . . . . 0.0 111.588 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.094 177.597 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.722 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 31.9 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -69.51 163.65 24.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.613 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -53.0 131.84 36.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.058 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.12 83.27 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.185 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 169.9 54.66 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.516 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -97.98 134.37 41.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.912 0.387 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -124.87 130.69 24.14 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.539 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.35 164.31 23.52 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.389 2.059 . . . . 0.0 111.092 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 56.5 m-20 -48.67 112.28 2.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 O-C-N 123.856 0.722 . . . . 0.0 112.016 -173.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 -27.3 52.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.348 2.699 . . . . 0.0 112.937 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.8 pt-20 -62.2 -40.69 96.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 5.3 tppp? -98.81 -46.22 5.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.3 mpt? -101.31 3.03 40.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.36 159.36 25.5 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.434 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' A' ' 24' ' ' CYS . 12.0 t70 -86.83 106.95 18.08 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.29 111.0 9.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.627 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.06 163.17 34.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.847 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.7 m -83.78 105.61 14.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.93 -102.63 1.89 Allowed Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -143.96 149.58 36.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.989 0.116 . . . . 0.0 110.722 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 36.2 t -97.45 110.32 22.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -128.28 111.59 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.211 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 59.81 48.91 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.23 24.56 14.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.008 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -133.19 150.74 51.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.824 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 81.5 m -100.74 119.04 38.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 30' ' ' ARG . 20.7 mtp180 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.555 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 20' ' ' CYS . 13.9 p . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.81 171.91 11.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 111.25 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -56.79 133.5 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.573 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -14.21 65.41 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.632 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.16 139.99 38.94 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.176 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -82.78 119.21 24.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.045 0.45 . . . . 0.0 110.245 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -115.54 127.03 27.13 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.759 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 26.5 Cg_endo -60.58 160.03 25.78 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.507 2.138 . . . . 0.0 111.166 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 6.2 m-20 -45.07 108.11 0.72 Allowed Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 124.357 1.036 . . . . 0.0 112.423 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -54.34 -29.08 56.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.384 2.723 . . . . 0.0 112.947 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.5 pt-20 -58.62 -38.64 78.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.93 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 24.3 tptm -99.1 -46.16 5.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.411 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.4 mpt? -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.25 146.12 5.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.492 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.55 110.01 9.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.521 ' CZ3' ' HB ' ' A' ' 4' ' ' VAL . 14.8 p-90 -128.6 112.05 13.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.109 0.956 . . . . 0.0 110.02 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' HG12 ' A' ' 4' ' ' VAL . 5.7 t -162.46 154.53 18.78 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.864 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.57 101.96 12.51 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 163.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -109.68 2.06 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.744 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.86 140.07 28.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -95.8 110.29 22.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.11 122.93 62.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.036 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 2.9 mmp_? 58.11 41.08 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.417 0.448 . . . . 0.0 110.358 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 66.66 19.36 10.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.131 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.21 151.98 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.7 t -100.48 123.42 44.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 109.909 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.167 -177.051 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.421 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 8.8 p . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.82 166.12 20.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.0 111.13 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -61.33 136.45 58.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.545 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.43 78.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.067 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.49 162.84 54.25 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.397 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.7 t80 -95.88 136.44 36.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.46 . . . . 0.0 110.892 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -132.24 150.87 77.19 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 18.2 Cg_endo -58.88 170.47 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.374 2.049 . . . . 0.0 111.592 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.619 ' OD1' ' HD3' ' A' ' 15' ' ' LYS . 9.0 t70 -46.22 109.05 0.91 Allowed Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.837 0.71 . . . . 0.0 111.427 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.45 -24.42 68.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.418 2.745 . . . . 0.0 113.887 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.65 -43.82 16.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.717 0.294 . . . . 0.0 110.93 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HD3' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -86.74 -45.32 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.185 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -92.78 -22.69 19.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.5 149.48 23.54 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.508 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.96 120.14 27.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.185 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.439 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 42.1 p-90 -125.25 113.18 17.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.767 0.794 . . . . 0.0 110.606 175.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 47.0 t -160.83 173.53 15.22 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.267 173.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 55.0 m -88.31 103.72 16.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 161.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.11 -117.51 3.67 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.76 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -144.94 135.57 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.854 0.327 . . . . 0.0 111.232 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -103.65 118.1 35.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.272 0.558 . . . . 0.0 109.725 175.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 26' ' ' ARG . 47.7 mt -136.32 130.23 47.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.213 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HG3' HG22 ' A' ' 25' ' ' ILE . 18.7 mtm180 65.76 36.64 6.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.556 0.342 . . . . 0.0 111.002 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 21.3 m120 64.5 15.93 9.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -132.94 149.71 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -101.74 134.99 44.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.706 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.783 -175.23 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.62 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.3 p . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -75.31 165.84 24.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.159 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -59.99 145.3 46.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.39 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.02 -11.24 67.73 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.641 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.28 142.3 40.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.816 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -84.34 131.94 34.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.5 p -136.01 142.52 40.56 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.71 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.04 158.4 43.88 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.349 2.033 . . . . 0.0 111.01 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.45 118.5 19.18 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.59 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.68 -28.74 48.11 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.702 2.935 . . . . 0.0 113.437 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -96.6 -45.85 6.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.4 mmm -110.56 0.68 17.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.64 30.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.214 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 22.7 t70 -86.95 114.59 23.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.629 0.252 . . . . 0.0 110.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -134.76 112.15 10.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.975 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' HG13 ' A' ' 4' ' ' VAL . 16.4 t -164.11 174.91 10.73 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.604 169.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 17.2 m -84.19 103.09 13.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.09 -117.14 4.32 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -144.77 140.67 28.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.951 0.375 . . . . 0.0 111.082 -178.256 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.7 t -98.24 117.32 32.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.42 122.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.989 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 61.49 41.51 12.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.076 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.9 m120 67.34 7.88 5.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.255 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -128.56 148.55 50.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -102.5 147.11 27.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.317 0.58 . . . . 0.0 111.845 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.479 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' CYS . 12.1 p . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.62 164.67 26.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.169 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 95.0 m-20 -59.27 133.11 55.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.235 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.75 -12.17 66.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.5 156.2 46.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.448 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.4 t80 -93.44 121.32 34.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.666 0.27 . . . . 0.0 110.869 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 4.3 p -129.07 126.66 23.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.915 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.49 172.09 7.18 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.725 2.284 . . . . 0.0 112.272 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 9.6 p-10 -55.56 121.51 39.09 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.401 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.23 -26.38 51.47 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.713 2.942 . . . . 0.0 113.671 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' C ' ' HE3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -68.3 -31.96 71.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -96.56 -45.47 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mpt? -114.48 0.61 14.08 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.3 152.91 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.69 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.81 119.93 30.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.206 0.527 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -122.74 112.15 17.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.673 0.749 . . . . 0.0 109.743 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 4' ' ' VAL . 14.4 t -162.5 155.96 20.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.747 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.99 102.44 14.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 -109.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.127 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -139.28 146.15 40.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.292 . . . . 0.0 110.799 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.45 110.99 23.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 26' ' ' ARG . 28.6 mt -136.14 127.49 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.965 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HG3' HG22 ' A' ' 25' ' ' ILE . 15.6 mtm180 62.65 33.44 15.66 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.62 0.368 . . . . 0.0 110.862 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 18.6 m120 61.97 20.65 11.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 110.811 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 32.5 mt-10 -116.38 156.23 27.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 38.4 t -102.66 119.68 39.25 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.478 ' HB ' ' SG ' ' A' ' 20' ' ' CYS . 47.3 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -87.68 166.42 14.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.741 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -57.25 133.97 55.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.27 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -3.11 76.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.249 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.57 148.61 49.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.011 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -89.44 130.55 35.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.786 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.7 p -124.72 147.5 56.28 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.31 170.67 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.217 1.945 . . . . 0.0 111.568 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.79 112.59 2.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.057 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 -27.23 67.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.086 2.524 . . . . 0.0 112.499 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -67.45 -33.08 74.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.114 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.65 -45.62 6.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -102.23 -14.71 16.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 155.87 25.99 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -171.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -86.3 123.55 31.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -129.53 112.46 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.555 0.693 . . . . 0.0 110.357 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 28.9 t -162.21 175.04 12.08 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.593 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.2 m -84.63 105.27 15.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 160.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.97 7.99 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -135.7 134.01 38.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -99.07 112.16 24.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 109.691 176.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.7 mt -120.13 120.55 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.892 -174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 57.08 50.38 12.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.366 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 65.3 13.28 8.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.213 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.33 147.57 52.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.8 t -102.14 137.44 40.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.406 0.622 . . . . 0.0 112.255 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.722 179.298 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' CG1' ' HA3' ' A' ' 8' ' ' GLY . 15.8 t . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.84 0.352 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.97 158.43 35.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.148 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -60.48 124.45 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.79 -10.14 58.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.264 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.4 ' HA3' ' CG1' ' A' ' 4' ' ' VAL . . . -66.68 152.23 52.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.384 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 48.9 t80 -92.28 128.11 38.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 0.0 110.563 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.2 p -121.38 133.4 24.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.339 -0.392 . . . . 0.0 109.991 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.58 167.88 14.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 111.939 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -42.66 109.25 0.72 Allowed Pre-proline 0 C--O 1.237 0.423 0 O-C-N 124.263 0.977 . . . . 0.0 112.613 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.86 -18.62 42.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.344 2.696 . . . . 0.0 112.641 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -62.56 -39.16 92.78 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -97.54 -45.44 6.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.75 -175.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.0 mtt -108.22 8.04 27.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.75 162.24 5.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.786 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -86.33 121.85 29.48 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -124.89 112.89 17.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.865 0.84 . . . . 0.0 109.589 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 35.5 t -160.55 163.22 32.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.654 -173.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -92.63 103.55 15.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 161.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.3 -109.97 2.4 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.023 -170.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -139.83 138.71 36.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 110.782 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -98.93 111.17 23.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 109.963 176.072 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.14 129.82 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.986 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 58.82 43.28 18.57 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.398 0.436 . . . . 0.0 111.006 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 28.8 m120 60.61 26.27 15.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.304 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 35.5 tt0 -131.37 150.8 52.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -100.73 119.55 38.78 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.805 -174.197 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.8 -175.06 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.25 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 2.3 p-10 -51.53 132.6 30.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.333 0.587 . . . . 0.0 111.268 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.16 13.33 17.93 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.301 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.32 141.6 15.37 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.606 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.94 111.95 23.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.9 p -114.95 123.26 32.18 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.986 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.513 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 84.6 Cg_exo -53.94 164.43 2.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.915 2.41 . . . . 0.0 112.287 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 12.3 t70 -37.6 114.91 0.74 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 124.29 0.994 . . . . 0.0 112.711 -171.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 44.6 Cg_exo -58.56 -42.33 55.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.333 2.689 . . . . 0.0 114.028 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -81.26 -37.06 29.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.601 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -96.14 -35.93 11.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.858 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 11' ' ' PRO . 64.4 mtt -103.87 -21.96 13.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.18 144.69 6.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.566 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 14.6 t70 -98.93 106.64 18.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.731 0.301 . . . . 0.0 110.459 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.513 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 30.6 p-90 -132.06 112.19 12.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.692 0.758 . . . . 0.0 110.208 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.09 173.19 16.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.667 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 t -84.5 105.35 15.25 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.23 1.73 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.832 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 1.1 tmt_? -144.67 146.85 32.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 34.6 t -97.31 113.06 24.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.9 mt -126.6 117.71 48.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.0 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 59.46 43.42 16.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 110.65 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 20.0 m120 62.93 26.72 15.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.398 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -133.02 153.35 51.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.599 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 90.5 m -101.81 124.99 48.37 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.207 0.527 . . . . 0.0 110.629 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.733 178.293 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.623 HG13 ' SG ' ' A' ' 29' ' ' CYS . 4.1 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.51 171.84 9.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.202 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 5.2 p-10 -52.62 137.96 29.47 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.486 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.69 69.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.742 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.71 150.57 28.25 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.172 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 27' ' ' ASN . 78.6 t80 -89.92 122.77 33.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -109.81 132.33 21.44 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.06 166.16 17.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.443 2.096 . . . . 0.0 111.508 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 14' ' ' GLU . 21.1 t70 -45.46 113.08 1.8 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.049 0.843 . . . . 0.0 111.87 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.2 Cg_exo -59.45 -20.96 59.21 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.211 2.607 . . . . 0.0 113.326 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 34.9 mm-40 -74.98 -33.58 61.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.521 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -96.34 -45.28 6.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.349 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.15 -8.36 25.26 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 163.87 38.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.876 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.08 107.12 13.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -135.86 112.41 10.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.072 0.939 . . . . 0.0 111.035 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.6 m -158.96 166.7 31.2 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.9 m -84.9 103.76 14.25 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 162.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.89 -117.67 4.22 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.72 149.48 49.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.716 0.258 . . . . 0.0 110.598 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 42.9 t -97.84 109.46 22.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.85 111.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.975 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 61.65 44.69 8.69 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.42 0.45 . . . . 0.0 110.881 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 22.3 m120 62.77 28.21 16.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.396 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -132.17 144.29 50.57 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' A' ' 4' ' ' VAL . 92.4 m -101.25 119.0 38.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.056 -177.42 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 20' ' ' CYS . 6.6 p . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.0 167.15 20.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.325 -172.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.1 p-10 -59.26 137.21 58.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.201 0.524 . . . . 0.0 110.738 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.41 -13.39 56.9 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.533 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.46 150.31 49.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.365 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.75 124.87 39.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -116.78 134.65 22.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.984 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.543 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 30.4 Cg_endo -63.19 159.99 36.66 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 111.461 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.74 116.5 6.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.281 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.36 -28.9 55.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.538 2.825 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.93 -37.41 84.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.473 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.6 OUTLIER -97.04 -45.99 6.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 11' ' ' PRO . 2.3 mpt? -102.18 -14.41 17.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -172.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.91 167.63 36.19 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -88.71 107.3 18.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -133.35 112.18 11.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.829 0.823 . . . . 0.0 110.188 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 4' ' ' VAL . 64.2 m -160.05 170.74 20.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.086 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.67 104.61 15.55 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 160.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.54 -113.03 3.84 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.21 -171.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -133.3 152.26 51.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.66 -0.318 . . . . 0.0 111.153 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -97.79 109.65 22.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 62.9 mt -129.16 115.92 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.248 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 60.66 40.45 16.44 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.183 0.302 . . . . 0.0 110.687 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.75 29.49 19.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.279 0.562 . . . . 0.0 110.844 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ILE . 36.5 tt0 -132.61 145.57 51.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.293 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 93.6 m -100.71 122.73 43.84 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.902 -178.568 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.672 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 23.7 t . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.94 162.95 27.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.922 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 94.3 m-20 -63.28 126.98 29.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.961 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.09 -4.04 84.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.035 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.75 52.9 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 57.3 t80 -88.46 117.72 27.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 p -112.66 130.97 22.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.444 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.99 161.64 25.25 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.336 2.024 . . . . 0.0 111.136 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.3 t70 -51.07 123.11 18.88 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.761 0.663 . . . . 0.0 111.572 -172.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 49.2 Cg_exo -58.06 -20.85 47.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.431 2.754 . . . . 0.0 114.028 -176.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -80.84 -25.94 37.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.62 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -45.86 6.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -108.15 -10.32 15.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.12 166.42 35.57 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.818 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.5 109.12 20.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.894 0.378 . . . . 0.0 110.295 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -135.49 111.05 9.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.806 0.812 . . . . 0.0 110.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.5 m -160.75 173.63 15.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.733 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 106.02 18.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . 107.99 -106.79 2.43 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' A' ' 22' ' ' GLY . 8.4 mpt_? -137.39 152.32 49.51 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.337 0.255 . . . . 0.0 110.387 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.6 t -96.92 110.2 22.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.93 120.46 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.2 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 60.07 32.8 21.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.646 0.378 . . . . 0.0 110.744 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 27.2 m120 66.13 23.49 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.853 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.82 151.09 40.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.878 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 74.7 m -102.95 120.2 40.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.409 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' O ' ' HA3' ' A' ' 22' ' ' GLY . 28.2 mtm180 . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.78 158.81 28.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.3 p-10 -58.19 126.89 29.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.094 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.53 -7.47 57.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.195 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.74 139.5 22.99 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.846 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -80.87 127.6 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.989 0.423 . . . . 0.0 110.172 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 p -117.45 137.47 24.15 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.814 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.51 169.2 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.629 2.219 . . . . 0.0 111.57 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -46.63 108.39 0.84 Allowed Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 123.982 0.801 . . . . 0.0 111.953 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.57 -20.23 63.53 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.005 2.47 . . . . 0.0 112.854 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.74 -36.9 83.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.603 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -98.07 -45.99 6.04 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.552 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.0 -3.97 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.51 161.64 33.54 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.093 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -86.29 113.7 22.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -132.4 111.2 11.11 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.037 0.923 . . . . 0.0 110.021 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.9 t -162.31 161.11 27.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.13 103.39 15.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 161.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.05 -109.88 2.19 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.815 -170.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.72 140.62 27.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.79 111.82 23.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.476 0.655 . . . . 0.0 109.921 175.587 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.5 mt -124.45 121.57 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.024 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 59.74 44.68 13.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.195 0.521 . . . . 0.0 110.707 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.9 m120 63.63 18.86 11.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.663 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -119.82 142.28 48.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 19.8 t -101.31 119.26 38.49 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.307 -175.575 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.471 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.3 p . . . . . 0 C--O 1.225 -0.233 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.07 168.82 19.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -54.57 143.49 24.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.357 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.69 -10.15 65.88 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.995 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 146.99 45.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.751 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -91.0 125.93 35.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -123.43 137.97 29.36 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.302 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.21 157.48 39.74 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.407 2.071 . . . . 0.0 111.421 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.78 113.01 2.69 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.452 -172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.91 -25.22 51.81 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.469 2.779 . . . . 0.0 112.875 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.64 -39.33 91.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -97.41 -45.44 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.542 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -105.45 1.58 27.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.41 155.24 16.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.975 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.91 117.56 20.11 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.319 0.248 . . . . 0.0 110.546 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -138.41 113.05 8.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.104 0.954 . . . . 0.0 111.078 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 4' ' ' VAL . 39.9 t -162.03 173.14 14.82 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.166 168.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 3.8 m -86.96 102.06 14.02 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 161.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.24 -121.82 5.25 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.34 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -137.0 137.08 39.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.041 0.421 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -98.18 112.11 24.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.52 125.5 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.826 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 63.91 38.89 8.55 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.121 0.263 . . . . 0.0 111.004 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 m120 65.27 11.84 7.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.386 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -133.53 158.54 42.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.5 t -101.59 135.94 42.26 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.025 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.062 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.412 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.0 p . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 178.73 6.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.024 -173.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 6.7 m-20 -52.86 138.06 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.014 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.71 -9.27 71.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.568 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.41 135.11 49.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.111 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -92.16 111.41 22.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 110.449 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -111.38 137.92 21.22 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 29.5 Cg_endo -61.12 163.53 16.62 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.314 2.009 . . . . 0.0 110.956 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.55 111.42 2.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.881 0.738 . . . . 0.0 111.232 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.24 -21.99 38.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.253 2.635 . . . . 0.0 113.262 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.2 -34.03 59.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 75.5 mmtt -97.06 -45.96 6.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.2 mpt? -98.2 -31.32 12.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.618 0.247 . . . . 0.0 111.561 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.76 156.18 9.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.9 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.82 106.52 18.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -129.4 111.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.756 0.789 . . . . 0.0 111.259 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.412 ' SG ' HG13 ' A' ' 4' ' ' VAL . 7.8 t -163.58 173.78 12.58 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.518 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.78 104.74 16.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 159.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.68 -136.12 9.55 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -127.47 139.13 53.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.128 0.464 . . . . 0.0 110.752 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -97.92 110.89 23.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.36 115.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.815 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 26' ' ' ARG . 22.1 mtp180 61.76 44.53 8.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.446 0.466 . . . . 0.0 110.842 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.98 24.51 13.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.292 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 34.9 mt-10 -125.0 152.33 44.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.198 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.2 m -102.34 119.92 39.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.829 -179.223 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.446 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 10.9 p . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.71 174.68 6.11 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.634 0.254 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -55.55 135.84 50.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.203 0.525 . . . . 0.0 111.109 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.19 -6.31 72.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 158.96 45.51 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.871 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -90.56 133.48 35.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.8 p -139.59 142.33 31.35 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.24 160.41 26.9 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.376 2.051 . . . . 0.0 111.075 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.12 110.5 1.81 Allowed Pre-proline 0 C--N 1.327 -0.4 0 O-C-N 124.006 0.816 . . . . 0.0 111.557 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.66 -24.73 64.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.098 2.532 . . . . 0.0 112.178 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.94 -40.78 85.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.545 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.45 -46.67 5.68 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -178.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.3 mpt? -96.28 1.15 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.86 156.9 24.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.398 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.48 108.53 17.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.743 0.306 . . . . 0.0 110.705 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -127.39 113.42 16.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.583 0.706 . . . . 0.0 110.251 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 4' ' ' VAL . 44.7 t -161.85 173.28 14.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.367 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 33.2 m -93.45 103.44 15.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 155.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.21 -128.46 7.99 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -166.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -141.62 134.87 29.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.303 0.551 . . . . 0.0 111.129 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -97.61 114.4 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.311 0.577 . . . . 0.0 110.004 177.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -131.68 116.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.94 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 64.12 44.75 4.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 111.477 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 22.3 m120 74.66 0.82 3.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.349 173.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.35 158.4 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 53.8 t -102.87 145.09 30.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.598 0.713 . . . . 0.0 111.783 -175.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.929 -178.416 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.512 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.2 p . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.62 177.75 5.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -52.58 138.71 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.37 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' HA2' ' OE2' ' A' ' 28' ' ' GLU . . . 86.69 0.85 85.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.357 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 146.44 21.14 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.172 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -85.35 120.96 27.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.437 . . . . 0.0 110.199 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 p -119.38 138.04 26.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.24 164.06 15.74 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.633 2.222 . . . . 0.0 111.526 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.585 ' OD1' ' HG2' ' A' ' 14' ' ' GLU . 8.9 t70 -52.74 127.28 42.91 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.671 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.92 -17.87 39.47 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.426 2.751 . . . . 0.0 114.139 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 6.6 pt-20 -77.41 -31.19 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.808 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 37.6 mmtm -97.73 -42.86 7.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -113.49 6.35 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.713 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.8 167.45 14.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.905 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -81.84 103.66 11.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -124.14 111.49 15.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.705 0.764 . . . . 0.0 110.624 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.512 ' SG ' HG13 ' A' ' 4' ' ' VAL . 22.9 t -164.01 174.36 11.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.874 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.05 102.43 14.49 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 155.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.34 -128.8 6.71 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.047 -170.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 9.6 mmt180 -141.12 137.64 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.107 0.453 . . . . 0.0 111.372 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.48 111.69 23.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 110.617 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.91 117.64 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.68 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 62.5 46.31 5.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.96 0.409 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 m120 61.65 18.27 9.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.905 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' OE2' ' HA2' ' A' ' 7' ' ' GLY . 46.4 tp10 -131.38 142.34 50.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 54.1 t -102.77 136.06 43.29 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.046 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.772 -178.115 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -97.88 136.51 38.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.005 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.45 151.21 25.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.287 0.565 . . . . 0.0 110.99 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.15 146.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.991 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.75 165.89 23.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.52 135.95 57.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.092 0.472 . . . . 0.0 111.502 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.09 -6.54 82.6 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.013 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.24 163.38 54.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.453 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.0 129.56 44.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.659 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.13 122.64 26.86 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.528 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD2' ' NE1' ' A' ' 19' ' ' TRP . 32.0 Cg_endo -62.04 169.05 8.08 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.863 2.375 . . . . 0.0 112.375 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.08 111.23 1.01 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 123.988 0.805 . . . . 0.0 112.512 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 54.0 Cg_exo -55.63 -27.87 62.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.374 2.716 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -71.2 -36.83 72.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.18 -46.19 5.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.12 -16.69 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.289 . . . . 0.0 111.582 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 154.92 31.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.516 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 13' ' ' PRO . 4.7 p-10 -88.74 130.27 35.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.081 0.467 . . . . 0.0 110.43 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.447 ' NE1' ' HD2' ' A' ' 11' ' ' PRO . 1.6 p-90 -143.2 113.57 7.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.773 0.797 . . . . 0.0 109.965 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.0 t -161.21 154.77 21.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.709 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.74 103.07 15.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 164.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 -105.09 1.13 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.067 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -144.33 144.71 31.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.673 0.236 . . . . 0.0 110.575 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 t -96.71 110.11 22.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.7 mt -130.06 122.61 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.91 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 59.34 40.06 21.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 110.663 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.0 m120 62.57 22.78 13.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.461 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.04 152.29 42.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.26 119.7 39.15 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.4 137.06 51.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.801 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -134.01 144.18 48.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.786 176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.221 -178.938 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -84.32 145.0 28.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.28 -177.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.6 m -135.26 168.93 18.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 20' ' ' CYS . 14.1 p -92.84 145.78 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 164.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -79.51 166.42 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.15 0.5 . . . . 0.0 111.544 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 21.2 t30 -59.76 125.33 23.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.622 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.18 -7.57 52.13 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.341 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.84 156.06 51.47 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.201 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -97.68 122.53 40.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.761 0.315 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 7.9 p -118.01 130.69 24.57 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 34.6 Cg_endo -62.98 166.65 13.77 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.28 1.987 . . . . 0.0 110.798 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.9 t70 -44.36 109.55 0.87 Allowed Pre-proline 0 C--N 1.329 -0.304 0 O-C-N 124.016 0.822 . . . . 0.0 111.281 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 31.6 Cg_exo -60.14 -29.67 89.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.163 2.575 . . . . 0.0 113.76 -171.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.49 -24.86 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.414 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -97.08 -45.21 6.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.5 mtt -110.47 3.76 19.89 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.88 142.47 13.16 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.543 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.1 117.58 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.524 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 5.9 p-90 -134.2 112.33 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.815 0.817 . . . . 0.0 110.549 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 42.9 t -161.07 159.46 29.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.115 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 103.81 14.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 163.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.92 -111.62 2.24 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.235 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -144.67 142.85 30.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.908 0.354 . . . . 0.0 110.819 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -98.71 111.51 23.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.251 176.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 25' ' ' ILE . 3.3 mp -112.73 114.16 46.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.037 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.72 56.75 6.37 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.503 0.502 . . . . 0.0 111.361 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 23.9 m120 66.64 19.01 10.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.424 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 36.1 tt0 -129.13 145.38 51.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 36.6 t -100.75 128.14 46.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -127.34 138.47 53.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.17 144.14 46.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.141 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.197 -1.335 . . . . 0.0 111.077 -178.226 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -79.61 142.25 35.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 15.0 p 56.98 150.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.0 113.294 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.702 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 t -92.63 133.38 34.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.751 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.32 163.93 21.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p-10 -61.92 133.71 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.276 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.21 4.26 84.08 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.03 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.62 153.66 24.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.951 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.56 121.75 29.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.826 0.346 . . . . 0.0 110.813 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -109.0 126.93 28.25 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.61 167.9 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.479 2.119 . . . . 0.0 111.525 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 4.2 m-20 -42.07 107.17 0.5 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 124.167 0.917 . . . . 0.0 112.889 -175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 48.1 Cg_exo -57.93 -26.42 74.46 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.168 2.579 . . . . 0.0 112.371 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 15' ' ' LYS . 7.0 pt-20 -57.07 -42.85 81.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.736 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 47.1 mmtm -98.82 -46.4 5.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -94.0 -5.24 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.02 155.62 26.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.066 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 12.6 t70 -78.31 96.73 5.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -125.63 112.28 15.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.161 0.981 . . . . 0.0 110.817 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 67.2 m -158.67 167.04 30.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.544 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -84.47 104.38 14.43 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 165.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -105.57 2.19 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -171.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -140.54 148.52 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.762 -0.258 . . . . 0.0 111.276 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 40.1 t -97.6 109.72 22.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.8 mt -128.8 110.64 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.377 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 63.37 39.94 8.91 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.42 0.45 . . . . 0.0 110.352 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.64 24.74 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.12 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -125.66 144.57 50.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 90.6 m -101.09 121.92 42.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.918 0.39 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -120.89 141.05 50.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.167 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -120.97 132.07 54.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.824 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.796 0 CA-C-O 118.729 -1.04 . . . . 0.0 112.045 -179.096 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.952 0.406 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.29 158.11 15.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.13 143.89 40.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.573 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.744 HG13 ' SG ' ' A' ' 20' ' ' CYS . 4.2 p -86.86 120.61 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.294 0.569 . . . . 0.0 109.679 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.13 -170.32 3.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.546 -170.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 25.7 p-10 -50.73 138.89 17.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.471 0.653 . . . . 0.0 111.885 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.5 71.67 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.787 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.33 153.07 49.02 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.148 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -99.05 131.07 45.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.236 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.7 p -132.94 143.24 47.76 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.82 164.97 27.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.28 1.986 . . . . 0.0 111.171 173.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 3.0 p-10 -52.53 112.51 3.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.718 0.636 . . . . 0.0 111.613 -177.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.5 Cg_exo -59.29 -21.51 60.76 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.492 2.794 . . . . 0.0 113.203 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 10.6 pt-20 -65.04 -40.57 95.0 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.124 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.3 mptm? -96.91 -45.92 6.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.05 0.23 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.78 161.76 23.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.949 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 13.3 t70 -89.48 114.16 25.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -137.55 109.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.523 0.678 . . . . 0.0 110.552 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.744 ' SG ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -164.87 174.37 10.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.08 172.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.38 104.99 14.87 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 162.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 -127.64 8.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -131.98 141.36 49.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 14.6 t -96.6 112.53 24.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.8 106.12 17.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.217 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 54.42 55.39 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.351 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.8 m120 72.16 5.52 5.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.188 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.6 143.77 50.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 73.0 m -103.08 134.3 46.74 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.107 0.48 . . . . 0.0 111.588 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -118.23 143.85 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.094 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.73 140.52 42.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.473 -1.182 . . . . 0.0 111.838 -177.813 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.279 0.562 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -145.12 164.03 32.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.16 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 24.6 p -71.44 157.99 37.07 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.722 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 31.9 t -83.28 124.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -69.51 163.65 24.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.613 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -53.0 131.84 36.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.058 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.12 83.27 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.185 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 169.9 54.66 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.516 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -97.98 134.37 41.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.912 0.387 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -124.87 130.69 24.14 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.539 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.35 164.31 23.52 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.389 2.059 . . . . 0.0 111.092 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 56.5 m-20 -48.67 112.28 2.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 O-C-N 123.856 0.722 . . . . 0.0 112.016 -173.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 -27.3 52.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.348 2.699 . . . . 0.0 112.937 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.8 pt-20 -62.2 -40.69 96.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 5.3 tppp? -98.81 -46.22 5.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.3 mpt? -101.31 3.03 40.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.36 159.36 25.5 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.434 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' A' ' 24' ' ' CYS . 12.0 t70 -86.83 106.95 18.08 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.29 111.0 9.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.627 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.584 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 33.2 m -160.06 163.17 34.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.847 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 33.7 m -83.78 105.61 14.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 166.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.93 -102.63 1.89 Allowed Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -143.96 149.58 36.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.989 0.116 . . . . 0.0 110.722 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 36.2 t -97.45 110.32 22.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -128.28 111.59 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.211 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 59.81 48.91 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.23 24.56 14.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.008 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -133.19 150.74 51.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.824 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 81.5 m -100.74 119.04 38.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 30' ' ' ARG . 20.7 mtp180 -117.02 138.88 51.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.555 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -150.84 135.38 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.553 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.322 -1.265 . . . . 0.0 111.447 -178.907 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 121.177 0.513 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.2 pm0 -92.6 158.64 15.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.228 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.4 p -119.73 147.08 45.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.97 0.414 . . . . 0.0 110.259 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 20' ' ' CYS . 13.9 p -90.12 147.46 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.81 171.91 11.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 111.25 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -56.79 133.5 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.573 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -14.21 65.41 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.632 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.16 139.99 38.94 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.176 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -82.78 119.21 24.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.045 0.45 . . . . 0.0 110.245 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -115.54 127.03 27.13 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.759 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 26.5 Cg_endo -60.58 160.03 25.78 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.507 2.138 . . . . 0.0 111.166 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 6.2 m-20 -45.07 108.11 0.72 Allowed Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 124.357 1.036 . . . . 0.0 112.423 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -54.34 -29.08 56.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.384 2.723 . . . . 0.0 112.947 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.5 pt-20 -58.62 -38.64 78.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.93 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 24.3 tptm -99.1 -46.16 5.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.411 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.4 mpt? -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.25 146.12 5.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.492 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.55 110.01 9.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.521 ' CZ3' ' HB ' ' A' ' 4' ' ' VAL . 14.8 p-90 -128.6 112.05 13.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.109 0.956 . . . . 0.0 110.02 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' HG12 ' A' ' 4' ' ' VAL . 5.7 t -162.46 154.53 18.78 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.864 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.57 101.96 12.51 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 163.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -109.68 2.06 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.744 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.86 140.07 28.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -95.8 110.29 22.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.11 122.93 62.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.036 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 2.9 mmp_? 58.11 41.08 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.417 0.448 . . . . 0.0 110.358 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 66.66 19.36 10.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.131 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.21 151.98 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.7 t -100.48 123.42 44.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 109.909 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -127.95 146.96 50.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.167 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -116.72 151.13 37.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.942 178.39 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.918 0.39 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -117.95 147.69 42.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.465 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 10.2 p -99.37 151.66 20.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.408 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 8.8 p -84.18 148.34 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.934 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.82 166.12 20.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.0 111.13 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -61.33 136.45 58.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.545 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.43 78.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.067 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.49 162.84 54.25 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.397 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.7 t80 -95.88 136.44 36.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.46 . . . . 0.0 110.892 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -132.24 150.87 77.19 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 18.2 Cg_endo -58.88 170.47 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.374 2.049 . . . . 0.0 111.592 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.619 ' OD1' ' HD3' ' A' ' 15' ' ' LYS . 9.0 t70 -46.22 109.05 0.91 Allowed Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.837 0.71 . . . . 0.0 111.427 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.45 -24.42 68.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.418 2.745 . . . . 0.0 113.887 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.65 -43.82 16.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.717 0.294 . . . . 0.0 110.93 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HD3' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -86.74 -45.32 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.185 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -92.78 -22.69 19.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.5 149.48 23.54 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.508 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.96 120.14 27.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.185 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.439 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 42.1 p-90 -125.25 113.18 17.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.767 0.794 . . . . 0.0 110.606 175.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 47.0 t -160.83 173.53 15.22 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.267 173.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 55.0 m -88.31 103.72 16.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 161.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.11 -117.51 3.67 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.76 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -144.94 135.57 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.854 0.327 . . . . 0.0 111.232 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -103.65 118.1 35.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.272 0.558 . . . . 0.0 109.725 175.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 26' ' ' ARG . 47.7 mt -136.32 130.23 47.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.213 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HG3' HG22 ' A' ' 25' ' ' ILE . 18.7 mtm180 65.76 36.64 6.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.556 0.342 . . . . 0.0 111.002 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 21.3 m120 64.5 15.93 9.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -132.94 149.71 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -101.74 134.99 44.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.706 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -120.99 151.36 39.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.783 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -118.53 106.41 12.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.737 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.504 -1.164 . . . . 0.0 111.515 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.656 0.265 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 11.8 pt-20 -82.09 167.76 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 7.7 p 52.9 172.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 113.047 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.3 p -87.37 145.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.008 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -75.31 165.84 24.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.159 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -59.99 145.3 46.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.39 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.02 -11.24 67.73 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.641 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.28 142.3 40.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.816 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -84.34 131.94 34.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.5 p -136.01 142.52 40.56 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.71 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.04 158.4 43.88 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.349 2.033 . . . . 0.0 111.01 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.45 118.5 19.18 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.59 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.68 -28.74 48.11 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.702 2.935 . . . . 0.0 113.437 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -96.6 -45.85 6.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.4 mmm -110.56 0.68 17.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.64 30.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.214 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 22.7 t70 -86.95 114.59 23.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.629 0.252 . . . . 0.0 110.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -134.76 112.15 10.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.975 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' HG13 ' A' ' 4' ' ' VAL . 16.4 t -164.11 174.91 10.73 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.604 169.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 17.2 m -84.19 103.09 13.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.09 -117.14 4.32 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -144.77 140.67 28.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.951 0.375 . . . . 0.0 111.082 -178.256 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.7 t -98.24 117.32 32.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.42 122.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.989 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 61.49 41.51 12.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.076 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.9 m120 67.34 7.88 5.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.255 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -128.56 148.55 50.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -102.5 147.11 27.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.317 0.58 . . . . 0.0 111.845 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.09 149.31 52.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -125.82 142.78 51.35 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.026 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.232 -179.389 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -145.48 119.06 9.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.9 p -112.44 148.95 33.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.043 0.449 . . . . 0.0 110.267 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' CYS . 12.1 p -85.38 145.99 7.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.62 164.67 26.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.169 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 95.0 m-20 -59.27 133.11 55.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.235 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.75 -12.17 66.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.5 156.2 46.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.448 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.4 t80 -93.44 121.32 34.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.666 0.27 . . . . 0.0 110.869 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 4.3 p -129.07 126.66 23.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.915 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.49 172.09 7.18 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.725 2.284 . . . . 0.0 112.272 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 9.6 p-10 -55.56 121.51 39.09 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.401 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.23 -26.38 51.47 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.713 2.942 . . . . 0.0 113.671 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' C ' ' HE3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -68.3 -31.96 71.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -96.56 -45.47 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mpt? -114.48 0.61 14.08 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.3 152.91 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.69 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.81 119.93 30.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.206 0.527 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -122.74 112.15 17.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.673 0.749 . . . . 0.0 109.743 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 4' ' ' VAL . 14.4 t -162.5 155.96 20.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.747 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.99 102.44 14.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 -109.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.127 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -139.28 146.15 40.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.292 . . . . 0.0 110.799 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.45 110.99 23.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 26' ' ' ARG . 28.6 mt -136.14 127.49 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.965 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HG3' HG22 ' A' ' 25' ' ' ILE . 15.6 mtm180 62.65 33.44 15.66 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.62 0.368 . . . . 0.0 110.862 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 18.6 m120 61.97 20.65 11.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 110.811 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 32.5 mt-10 -116.38 156.23 27.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 38.4 t -102.66 119.68 39.25 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -132.46 151.83 51.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -98.0 142.21 30.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.592 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.334 -1.259 . . . . 0.0 111.265 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.058 0.456 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -104.46 156.97 17.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.047 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.8 p -136.95 170.66 15.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.848 0.356 . . . . 0.0 110.446 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.478 ' HB ' ' SG ' ' A' ' 20' ' ' CYS . 47.3 t -77.9 147.05 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.112 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -87.68 166.42 14.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.741 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -57.25 133.97 55.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.27 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -3.11 76.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.249 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.57 148.61 49.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.011 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -89.44 130.55 35.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.786 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.7 p -124.72 147.5 56.28 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.31 170.67 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.217 1.945 . . . . 0.0 111.568 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.79 112.59 2.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.057 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 -27.23 67.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.086 2.524 . . . . 0.0 112.499 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -67.45 -33.08 74.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.114 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.65 -45.62 6.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -102.23 -14.71 16.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 155.87 25.99 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -171.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -86.3 123.55 31.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -129.53 112.46 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.555 0.693 . . . . 0.0 110.357 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 28.9 t -162.21 175.04 12.08 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.593 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.2 m -84.63 105.27 15.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 160.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.97 7.99 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -135.7 134.01 38.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -99.07 112.16 24.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 109.691 176.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.7 mt -120.13 120.55 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.892 -174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 57.08 50.38 12.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.366 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 65.3 13.28 8.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.213 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.33 147.57 52.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.8 t -102.14 137.44 40.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.406 0.622 . . . . 0.0 112.255 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -131.1 147.25 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.722 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -129.06 151.54 49.63 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.529 -1.151 . . . . 0.0 111.867 -179.238 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.804 0.335 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.76 156.79 21.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.444 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.7 p -99.84 163.2 12.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.916 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' CG1' ' HA3' ' A' ' 8' ' ' GLY . 15.8 t -91.49 146.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.352 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.97 158.43 35.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.148 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -60.48 124.45 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.79 -10.14 58.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.264 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.4 ' HA3' ' CG1' ' A' ' 4' ' ' VAL . . . -66.68 152.23 52.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.384 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 48.9 t80 -92.28 128.11 38.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 0.0 110.563 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.2 p -121.38 133.4 24.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.339 -0.392 . . . . 0.0 109.991 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.58 167.88 14.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 111.939 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -42.66 109.25 0.72 Allowed Pre-proline 0 C--O 1.237 0.423 0 O-C-N 124.263 0.977 . . . . 0.0 112.613 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.86 -18.62 42.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.344 2.696 . . . . 0.0 112.641 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -62.56 -39.16 92.78 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -97.54 -45.44 6.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.75 -175.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.0 mtt -108.22 8.04 27.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.75 162.24 5.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.786 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -86.33 121.85 29.48 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -124.89 112.89 17.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.865 0.84 . . . . 0.0 109.589 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 35.5 t -160.55 163.22 32.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.654 -173.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -92.63 103.55 15.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 161.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.3 -109.97 2.4 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.023 -170.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -139.83 138.71 36.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 110.782 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -98.93 111.17 23.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 109.963 176.072 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.14 129.82 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.986 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 58.82 43.28 18.57 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.398 0.436 . . . . 0.0 111.006 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 28.8 m120 60.61 26.27 15.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.304 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 35.5 tt0 -131.37 150.8 52.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -100.73 119.55 38.78 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -125.04 144.63 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.805 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -144.13 147.16 33.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.652 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.467 -1.185 . . . . 0.0 111.895 -178.769 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.757 0.313 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.34 136.13 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 110.503 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -88.04 141.77 28.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.858 0.361 . . . . 0.0 110.083 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.22 121.62 33.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.796 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.8 -175.06 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.25 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 2.3 p-10 -51.53 132.6 30.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.333 0.587 . . . . 0.0 111.268 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.16 13.33 17.93 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.301 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.32 141.6 15.37 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.606 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.94 111.95 23.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.9 p -114.95 123.26 32.18 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.986 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.513 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 84.6 Cg_exo -53.94 164.43 2.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.915 2.41 . . . . 0.0 112.287 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 12.3 t70 -37.6 114.91 0.74 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 124.29 0.994 . . . . 0.0 112.711 -171.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 44.6 Cg_exo -58.56 -42.33 55.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.333 2.689 . . . . 0.0 114.028 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -81.26 -37.06 29.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.601 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -96.14 -35.93 11.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.858 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 11' ' ' PRO . 64.4 mtt -103.87 -21.96 13.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.18 144.69 6.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.566 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 14.6 t70 -98.93 106.64 18.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.731 0.301 . . . . 0.0 110.459 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.513 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 30.6 p-90 -132.06 112.19 12.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.692 0.758 . . . . 0.0 110.208 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.09 173.19 16.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.667 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 t -84.5 105.35 15.25 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.23 1.73 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.832 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 1.1 tmt_? -144.67 146.85 32.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 34.6 t -97.31 113.06 24.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.9 mt -126.6 117.71 48.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.0 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 59.46 43.42 16.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 110.65 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 20.0 m120 62.93 26.72 15.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.398 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -133.02 153.35 51.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.599 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 90.5 m -101.81 124.99 48.37 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.207 0.527 . . . . 0.0 110.629 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -106.39 113.85 27.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.733 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -100.65 97.21 7.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.675 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.284 -1.287 . . . . 0.0 111.308 -177.173 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.89 0.376 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.77 143.29 28.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 110.255 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 31.6 p -118.81 158.14 26.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.865 0.364 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.623 HG13 ' SG ' ' A' ' 29' ' ' CYS . 4.1 p -104.73 129.04 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.51 171.84 9.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.202 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 5.2 p-10 -52.62 137.96 29.47 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.486 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.69 69.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.742 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.71 150.57 28.25 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.172 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 27' ' ' ASN . 78.6 t80 -89.92 122.77 33.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -109.81 132.33 21.44 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.06 166.16 17.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.443 2.096 . . . . 0.0 111.508 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 14' ' ' GLU . 21.1 t70 -45.46 113.08 1.8 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.049 0.843 . . . . 0.0 111.87 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.2 Cg_exo -59.45 -20.96 59.21 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.211 2.607 . . . . 0.0 113.326 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 34.9 mm-40 -74.98 -33.58 61.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.521 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -96.34 -45.28 6.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.349 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.15 -8.36 25.26 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 163.87 38.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.876 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.08 107.12 13.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -135.86 112.41 10.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.072 0.939 . . . . 0.0 111.035 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 88.6 m -158.96 166.7 31.2 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.9 m -84.9 103.76 14.25 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 162.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.89 -117.67 4.22 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.72 149.48 49.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.716 0.258 . . . . 0.0 110.598 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 42.9 t -97.84 109.46 22.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.85 111.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.975 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 61.65 44.69 8.69 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.42 0.45 . . . . 0.0 110.881 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 22.3 m120 62.77 28.21 16.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.396 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -132.17 144.29 50.57 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' A' ' 4' ' ' VAL . 92.4 m -101.25 119.0 38.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -123.09 143.94 49.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.056 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -134.87 142.46 46.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -1.32 . . . . 0.0 111.235 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.6 119.1 16.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.979 0.419 . . . . 0.0 110.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -88.41 140.15 29.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.921 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 20' ' ' CYS . 6.6 p -76.21 130.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.0 167.15 20.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.325 -172.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.1 p-10 -59.26 137.21 58.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.201 0.524 . . . . 0.0 110.738 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.41 -13.39 56.9 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.533 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.46 150.31 49.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.365 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.75 124.87 39.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -116.78 134.65 22.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.984 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.543 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 30.4 Cg_endo -63.19 159.99 36.66 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 111.461 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.74 116.5 6.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.281 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.36 -28.9 55.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.538 2.825 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.93 -37.41 84.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.473 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.6 OUTLIER -97.04 -45.99 6.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 11' ' ' PRO . 2.3 mpt? -102.18 -14.41 17.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -172.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.91 167.63 36.19 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -88.71 107.3 18.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -133.35 112.18 11.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.829 0.823 . . . . 0.0 110.188 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 4' ' ' VAL . 64.2 m -160.05 170.74 20.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.086 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.67 104.61 15.55 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 160.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.54 -113.03 3.84 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.21 -171.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -133.3 152.26 51.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.66 -0.318 . . . . 0.0 111.153 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -97.79 109.65 22.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 62.9 mt -129.16 115.92 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.248 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 60.66 40.45 16.44 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.183 0.302 . . . . 0.0 110.687 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.75 29.49 19.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.279 0.562 . . . . 0.0 110.844 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ILE . 36.5 tt0 -132.61 145.57 51.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.293 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 93.6 m -100.71 122.73 43.84 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -126.11 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.902 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -107.13 161.02 15.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.14 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.893 -0.949 . . . . 0.0 111.29 179.812 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -88.24 135.86 33.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 0.0 110.159 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 p -94.25 156.33 16.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.91 0.386 . . . . 0.0 110.538 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 23.7 t -83.35 140.06 16.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.668 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.94 162.95 27.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.922 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 94.3 m-20 -63.28 126.98 29.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.961 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.09 -4.04 84.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.035 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.75 52.9 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 57.3 t80 -88.46 117.72 27.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 p -112.66 130.97 22.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.444 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.99 161.64 25.25 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.336 2.024 . . . . 0.0 111.136 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.3 t70 -51.07 123.11 18.88 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.761 0.663 . . . . 0.0 111.572 -172.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 49.2 Cg_exo -58.06 -20.85 47.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.431 2.754 . . . . 0.0 114.028 -176.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -80.84 -25.94 37.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.62 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -45.86 6.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -108.15 -10.32 15.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.12 166.42 35.57 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.818 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.5 109.12 20.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.894 0.378 . . . . 0.0 110.295 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -135.49 111.05 9.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.806 0.812 . . . . 0.0 110.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.5 m -160.75 173.63 15.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.733 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 106.02 18.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . 107.99 -106.79 2.43 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' A' ' 22' ' ' GLY . 8.4 mpt_? -137.39 152.32 49.51 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.337 0.255 . . . . 0.0 110.387 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.6 t -96.92 110.2 22.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.93 120.46 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.2 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 60.07 32.8 21.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.646 0.378 . . . . 0.0 110.744 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 27.2 m120 66.13 23.49 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.853 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.82 151.09 40.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.878 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 74.7 m -102.95 120.2 40.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.409 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' O ' ' HA3' ' A' ' 22' ' ' GLY . 28.2 mtm180 -118.77 130.29 55.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -117.78 138.59 51.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.307 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.921 -0.933 . . . . 0.0 111.32 -178.874 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 120.741 0.305 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.86 136.64 33.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.413 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.1 p 52.67 -177.23 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.164 0.985 . . . . 0.0 112.652 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.36 143.6 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.78 158.81 28.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.3 p-10 -58.19 126.89 29.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.094 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.53 -7.47 57.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.195 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.74 139.5 22.99 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.846 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -80.87 127.6 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.989 0.423 . . . . 0.0 110.172 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 p -117.45 137.47 24.15 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.814 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.51 169.2 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.629 2.219 . . . . 0.0 111.57 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -46.63 108.39 0.84 Allowed Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 123.982 0.801 . . . . 0.0 111.953 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.57 -20.23 63.53 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.005 2.47 . . . . 0.0 112.854 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.74 -36.9 83.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.603 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -98.07 -45.99 6.04 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.552 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.0 -3.97 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.51 161.64 33.54 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.093 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -86.29 113.7 22.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -132.4 111.2 11.11 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.037 0.923 . . . . 0.0 110.021 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.9 t -162.31 161.11 27.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.13 103.39 15.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 161.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.05 -109.88 2.19 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.815 -170.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.72 140.62 27.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.79 111.82 23.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.476 0.655 . . . . 0.0 109.921 175.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.5 mt -124.45 121.57 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.024 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 59.74 44.68 13.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.195 0.521 . . . . 0.0 110.707 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.9 m120 63.63 18.86 11.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.663 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -119.82 142.28 48.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 19.8 t -101.31 119.26 38.49 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -113.8 128.55 56.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.307 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -115.53 106.47 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.627 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.932 -0.926 . . . . 0.0 111.43 177.406 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -64.89 140.34 58.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.505 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 24.9 p -115.36 151.78 34.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.345 0.593 . . . . 0.0 111.749 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.3 p -82.2 148.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.483 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.07 168.82 19.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -54.57 143.49 24.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.357 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.69 -10.15 65.88 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.995 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 146.99 45.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.751 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -91.0 125.93 35.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -123.43 137.97 29.36 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.302 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.21 157.48 39.74 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.407 2.071 . . . . 0.0 111.421 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.78 113.01 2.69 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.452 -172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.91 -25.22 51.81 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.469 2.779 . . . . 0.0 112.875 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.64 -39.33 91.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -97.41 -45.44 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.542 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -105.45 1.58 27.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.41 155.24 16.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.975 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.91 117.56 20.11 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.319 0.248 . . . . 0.0 110.546 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -138.41 113.05 8.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.104 0.954 . . . . 0.0 111.078 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.55 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 39.9 t -162.03 173.14 14.82 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.166 168.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.8 m -86.96 102.06 14.02 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 161.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.24 -121.82 5.25 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.34 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -137.0 137.08 39.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.041 0.421 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -98.18 112.11 24.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.52 125.5 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.826 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 63.91 38.89 8.55 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.121 0.263 . . . . 0.0 111.004 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 m120 65.27 11.84 7.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.386 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -133.53 158.54 42.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.5 t -101.59 135.94 42.26 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.025 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -116.8 150.6 38.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.062 -177.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -87.47 -15.84 36.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.172 0.511 . . . . 0.0 109.858 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.592 179.48 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.025 0.44 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.99 147.25 45.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.474 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.8 m -106.85 160.62 15.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.933 0.397 . . . . 0.0 110.948 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.412 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.0 p -79.54 136.77 22.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.459 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 178.73 6.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.024 -173.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 6.7 m-20 -52.86 138.06 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.014 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.71 -9.27 71.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.568 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.41 135.11 49.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.111 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -92.16 111.41 22.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 110.449 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -111.38 137.92 21.22 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 29.5 Cg_endo -61.12 163.53 16.62 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.314 2.009 . . . . 0.0 110.956 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.55 111.42 2.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.881 0.738 . . . . 0.0 111.232 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.24 -21.99 38.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.253 2.635 . . . . 0.0 113.262 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.2 -34.03 59.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 75.5 mmtt -97.06 -45.96 6.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.2 mpt? -98.2 -31.32 12.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.618 0.247 . . . . 0.0 111.561 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.76 156.18 9.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.9 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.82 106.52 18.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -129.4 111.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.756 0.789 . . . . 0.0 111.259 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.412 ' SG ' HG13 ' A' ' 4' ' ' VAL . 7.8 t -163.58 173.78 12.58 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.518 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.78 104.74 16.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 159.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.68 -136.12 9.55 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -127.47 139.13 53.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.128 0.464 . . . . 0.0 110.752 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -97.92 110.89 23.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.36 115.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.815 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 26' ' ' ARG . 22.1 mtp180 61.76 44.53 8.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.446 0.466 . . . . 0.0 110.842 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.98 24.51 13.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.292 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 34.9 mt-10 -125.0 152.33 44.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.198 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.2 m -102.34 119.92 39.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -131.0 111.56 12.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.829 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -96.28 70.29 2.73 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.604 -1.109 . . . . 0.0 111.452 -176.895 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.908 0.385 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -115.87 141.77 47.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.9 p -94.23 148.24 22.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.74 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.446 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 10.9 p -75.81 147.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.71 174.68 6.11 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.634 0.254 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -55.55 135.84 50.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.203 0.525 . . . . 0.0 111.109 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.19 -6.31 72.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 158.96 45.51 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.871 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -90.56 133.48 35.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.8 p -139.59 142.33 31.35 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.24 160.41 26.9 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.376 2.051 . . . . 0.0 111.075 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.12 110.5 1.81 Allowed Pre-proline 0 C--N 1.327 -0.4 0 O-C-N 124.006 0.816 . . . . 0.0 111.557 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.66 -24.73 64.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.098 2.532 . . . . 0.0 112.178 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.94 -40.78 85.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.545 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.45 -46.67 5.68 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -178.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.3 mpt? -96.28 1.15 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.86 156.9 24.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.398 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.48 108.53 17.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.743 0.306 . . . . 0.0 110.705 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -127.39 113.42 16.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.583 0.706 . . . . 0.0 110.251 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 4' ' ' VAL . 44.7 t -161.85 173.28 14.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.367 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 33.2 m -93.45 103.44 15.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 155.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.21 -128.46 7.99 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -166.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -141.62 134.87 29.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.303 0.551 . . . . 0.0 111.129 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -97.61 114.4 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.311 0.577 . . . . 0.0 110.004 177.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -131.68 116.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.94 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 64.12 44.75 4.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 111.477 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 22.3 m120 74.66 0.82 3.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.349 173.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.35 158.4 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 53.8 t -102.87 145.09 30.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.598 0.713 . . . . 0.0 111.783 -175.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -128.1 147.28 50.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.929 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -144.2 153.01 41.64 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.706 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.915 -1.492 . . . . 0.0 111.02 178.428 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.771 0.32 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.24 134.69 50.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.188 0.518 . . . . 0.0 110.48 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 p -111.04 153.04 26.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.512 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.2 p -79.79 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.62 177.75 5.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -52.58 138.71 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.37 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' HA2' ' OE2' ' A' ' 28' ' ' GLU . . . 86.69 0.85 85.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.357 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 146.44 21.14 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.172 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -85.35 120.96 27.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.437 . . . . 0.0 110.199 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 p -119.38 138.04 26.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.24 164.06 15.74 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.633 2.222 . . . . 0.0 111.526 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.585 ' OD1' ' HG2' ' A' ' 14' ' ' GLU . 8.9 t70 -52.74 127.28 42.91 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.671 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.92 -17.87 39.47 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.426 2.751 . . . . 0.0 114.139 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 6.6 pt-20 -77.41 -31.19 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.808 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 37.6 mmtm -97.73 -42.86 7.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -113.49 6.35 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.713 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.8 167.45 14.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.905 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -81.84 103.66 11.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -124.14 111.49 15.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.705 0.764 . . . . 0.0 110.624 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.512 ' SG ' HG13 ' A' ' 4' ' ' VAL . 22.9 t -164.01 174.36 11.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.874 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.05 102.43 14.49 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 155.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.34 -128.8 6.71 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.047 -170.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 9.6 mmt180 -141.12 137.64 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.107 0.453 . . . . 0.0 111.372 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.48 111.69 23.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 110.617 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.91 117.64 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.68 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 62.5 46.31 5.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.96 0.409 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 m120 61.65 18.27 9.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.905 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' OE2' ' HA2' ' A' ' 7' ' ' GLY . 46.4 tp10 -131.38 142.34 50.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 54.1 t -102.77 136.06 43.29 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.046 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -140.16 -179.61 6.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.772 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -130.39 163.24 27.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.399 177.195 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.75 165.89 23.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.52 135.95 57.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.092 0.472 . . . . 0.0 111.502 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.09 -6.54 82.6 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.013 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.24 163.38 54.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.453 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.0 129.56 44.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.659 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.13 122.64 26.86 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.528 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD2' ' NE1' ' A' ' 19' ' ' TRP . 32.0 Cg_endo -62.04 169.05 8.08 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.863 2.375 . . . . 0.0 112.375 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.08 111.23 1.01 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 123.988 0.805 . . . . 0.0 112.512 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 54.0 Cg_exo -55.63 -27.87 62.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.374 2.716 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -71.2 -36.83 72.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.18 -46.19 5.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.12 -16.69 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.289 . . . . 0.0 111.582 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 154.92 31.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.516 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 13' ' ' PRO . 4.7 p-10 -88.74 130.27 35.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.081 0.467 . . . . 0.0 110.43 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.447 ' NE1' ' HD2' ' A' ' 11' ' ' PRO . 1.6 p-90 -143.2 113.57 7.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.773 0.797 . . . . 0.0 109.965 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.0 t -161.21 154.77 21.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.709 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.74 103.07 15.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 164.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 -105.09 1.13 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.067 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -144.33 144.71 31.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.673 0.236 . . . . 0.0 110.575 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 t -96.71 110.11 22.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.7 mt -130.06 122.61 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.91 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 59.34 40.06 21.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 110.663 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.0 m120 62.57 22.78 13.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.461 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.04 152.29 42.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.26 119.7 39.15 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.801 -174.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 20' ' ' CYS . 14.1 p . . . . . 0 N--CA 1.444 -0.75 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -79.51 166.42 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.15 0.5 . . . . 0.0 111.544 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 21.2 t30 -59.76 125.33 23.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.622 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.18 -7.57 52.13 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.341 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.84 156.06 51.47 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.201 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -97.68 122.53 40.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.761 0.315 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 7.9 p -118.01 130.69 24.57 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 34.6 Cg_endo -62.98 166.65 13.77 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.28 1.987 . . . . 0.0 110.798 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.9 t70 -44.36 109.55 0.87 Allowed Pre-proline 0 C--N 1.329 -0.304 0 O-C-N 124.016 0.822 . . . . 0.0 111.281 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 31.6 Cg_exo -60.14 -29.67 89.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.163 2.575 . . . . 0.0 113.76 -171.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.49 -24.86 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.414 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -97.08 -45.21 6.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.5 mtt -110.47 3.76 19.89 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.88 142.47 13.16 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.543 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.1 117.58 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.524 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 5.9 p-90 -134.2 112.33 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.815 0.817 . . . . 0.0 110.549 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 42.9 t -161.07 159.46 29.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.115 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 103.81 14.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 163.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.92 -111.62 2.24 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.235 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -144.67 142.85 30.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.908 0.354 . . . . 0.0 110.819 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -98.71 111.51 23.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.251 176.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 25' ' ' ILE . 3.3 mp -112.73 114.16 46.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.037 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.72 56.75 6.37 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.503 0.502 . . . . 0.0 111.361 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 23.9 m120 66.64 19.01 10.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.424 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 36.1 tt0 -129.13 145.38 51.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 36.6 t -100.75 128.14 46.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 -177.762 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.702 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 t . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.32 163.93 21.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p-10 -61.92 133.71 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.276 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.21 4.26 84.08 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.03 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.62 153.66 24.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.951 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.56 121.75 29.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.826 0.346 . . . . 0.0 110.813 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -109.0 126.93 28.25 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.61 167.9 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.479 2.119 . . . . 0.0 111.525 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 4.2 m-20 -42.07 107.17 0.5 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 124.167 0.917 . . . . 0.0 112.889 -175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 48.1 Cg_exo -57.93 -26.42 74.46 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.168 2.579 . . . . 0.0 112.371 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 15' ' ' LYS . 7.0 pt-20 -57.07 -42.85 81.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.736 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 47.1 mmtm -98.82 -46.4 5.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -94.0 -5.24 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.02 155.62 26.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.066 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 12.6 t70 -78.31 96.73 5.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -125.63 112.28 15.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.161 0.981 . . . . 0.0 110.817 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 67.2 m -158.67 167.04 30.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.544 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -84.47 104.38 14.43 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 165.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -105.57 2.19 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -171.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -140.54 148.52 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.762 -0.258 . . . . 0.0 111.276 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 40.1 t -97.6 109.72 22.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.8 mt -128.8 110.64 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.377 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 63.37 39.94 8.91 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.42 0.45 . . . . 0.0 110.352 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.64 24.74 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.12 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -125.66 144.57 50.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 90.6 m -101.09 121.92 42.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.918 0.39 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.167 -179.18 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.744 HG13 ' SG ' ' A' ' 20' ' ' CYS . 4.2 p . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.294 0.569 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.13 -170.32 3.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.546 -170.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 25.7 p-10 -50.73 138.89 17.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.471 0.653 . . . . 0.0 111.885 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.5 71.67 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.787 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.33 153.07 49.02 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.148 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -99.05 131.07 45.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.236 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.7 p -132.94 143.24 47.76 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.82 164.97 27.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.28 1.986 . . . . 0.0 111.171 173.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 3.0 p-10 -52.53 112.51 3.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.718 0.636 . . . . 0.0 111.613 -177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.5 Cg_exo -59.29 -21.51 60.76 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.492 2.794 . . . . 0.0 113.203 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 10.6 pt-20 -65.04 -40.57 95.0 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.124 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.3 mptm? -96.91 -45.92 6.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.05 0.23 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.78 161.76 23.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.949 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 13.3 t70 -89.48 114.16 25.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -137.55 109.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.523 0.678 . . . . 0.0 110.552 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.744 ' SG ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -164.87 174.37 10.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.08 172.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.38 104.99 14.87 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 162.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 -127.64 8.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -131.98 141.36 49.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 14.6 t -96.6 112.53 24.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.8 106.12 17.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.217 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 54.42 55.39 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.351 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.8 m120 72.16 5.52 5.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.188 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.6 143.77 50.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 73.0 m -103.08 134.3 46.74 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.107 0.48 . . . . 0.0 111.588 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.094 177.597 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.722 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 31.9 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -69.51 163.65 24.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.613 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -53.0 131.84 36.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.058 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.12 83.27 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.185 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 169.9 54.66 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.516 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -97.98 134.37 41.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.912 0.387 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -124.87 130.69 24.14 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.539 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.35 164.31 23.52 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.389 2.059 . . . . 0.0 111.092 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 56.5 m-20 -48.67 112.28 2.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 O-C-N 123.856 0.722 . . . . 0.0 112.016 -173.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 -27.3 52.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.348 2.699 . . . . 0.0 112.937 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.8 pt-20 -62.2 -40.69 96.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 5.3 tppp? -98.81 -46.22 5.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.3 mpt? -101.31 3.03 40.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.36 159.36 25.5 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.434 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' A' ' 24' ' ' CYS . 12.0 t70 -86.83 106.95 18.08 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.29 111.0 9.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.627 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.06 163.17 34.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.847 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.7 m -83.78 105.61 14.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 166.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.93 -102.63 1.89 Allowed Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -143.96 149.58 36.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.989 0.116 . . . . 0.0 110.722 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 36.2 t -97.45 110.32 22.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -128.28 111.59 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.211 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 59.81 48.91 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.23 24.56 14.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.008 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -133.19 150.74 51.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.824 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 81.5 m -100.74 119.04 38.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 30' ' ' ARG . 20.7 mtp180 . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.555 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 20' ' ' CYS . 13.9 p . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.81 171.91 11.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 111.25 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -56.79 133.5 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.573 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -14.21 65.41 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.632 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.16 139.99 38.94 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.176 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -82.78 119.21 24.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.045 0.45 . . . . 0.0 110.245 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -115.54 127.03 27.13 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.759 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 26.5 Cg_endo -60.58 160.03 25.78 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.507 2.138 . . . . 0.0 111.166 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 6.2 m-20 -45.07 108.11 0.72 Allowed Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 124.357 1.036 . . . . 0.0 112.423 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -54.34 -29.08 56.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.384 2.723 . . . . 0.0 112.947 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.5 pt-20 -58.62 -38.64 78.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.93 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 24.3 tptm -99.1 -46.16 5.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.411 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.4 mpt? -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.25 146.12 5.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.492 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.55 110.01 9.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.521 ' CZ3' ' HB ' ' A' ' 4' ' ' VAL . 14.8 p-90 -128.6 112.05 13.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.109 0.956 . . . . 0.0 110.02 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' HG12 ' A' ' 4' ' ' VAL . 5.7 t -162.46 154.53 18.78 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.864 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.57 101.96 12.51 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 163.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -109.68 2.06 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.744 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.86 140.07 28.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -95.8 110.29 22.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.11 122.93 62.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.036 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 2.9 mmp_? 58.11 41.08 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.417 0.448 . . . . 0.0 110.358 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 66.66 19.36 10.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.131 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.21 151.98 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.7 t -100.48 123.42 44.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 109.909 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.167 -177.051 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.421 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 8.8 p . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.82 166.12 20.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.0 111.13 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -61.33 136.45 58.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.545 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.43 78.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.067 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.49 162.84 54.25 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.397 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.7 t80 -95.88 136.44 36.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.46 . . . . 0.0 110.892 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -132.24 150.87 77.19 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 18.2 Cg_endo -58.88 170.47 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.374 2.049 . . . . 0.0 111.592 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.619 ' OD1' ' HD3' ' A' ' 15' ' ' LYS . 9.0 t70 -46.22 109.05 0.91 Allowed Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.837 0.71 . . . . 0.0 111.427 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.45 -24.42 68.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.418 2.745 . . . . 0.0 113.887 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.65 -43.82 16.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.717 0.294 . . . . 0.0 110.93 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HD3' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -86.74 -45.32 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.185 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -92.78 -22.69 19.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.5 149.48 23.54 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.508 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.96 120.14 27.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.185 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.439 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 42.1 p-90 -125.25 113.18 17.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.767 0.794 . . . . 0.0 110.606 175.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 21' ' ' CYS . 47.0 t -160.83 173.53 15.22 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.267 173.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 55.0 m -88.31 103.72 16.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 161.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.11 -117.51 3.67 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.76 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -144.94 135.57 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.854 0.327 . . . . 0.0 111.232 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -103.65 118.1 35.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.272 0.558 . . . . 0.0 109.725 175.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 26' ' ' ARG . 47.7 mt -136.32 130.23 47.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.213 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HG3' HG22 ' A' ' 25' ' ' ILE . 18.7 mtm180 65.76 36.64 6.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.556 0.342 . . . . 0.0 111.002 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 21.3 m120 64.5 15.93 9.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -132.94 149.71 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -101.74 134.99 44.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.706 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.783 -175.23 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.62 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.3 p . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -75.31 165.84 24.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.159 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -59.99 145.3 46.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.39 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.02 -11.24 67.73 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.641 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.28 142.3 40.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.816 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -84.34 131.94 34.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.5 p -136.01 142.52 40.56 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.71 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.04 158.4 43.88 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.349 2.033 . . . . 0.0 111.01 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.45 118.5 19.18 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.59 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.68 -28.74 48.11 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.702 2.935 . . . . 0.0 113.437 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -96.6 -45.85 6.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.4 mmm -110.56 0.68 17.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.64 30.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.214 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 22.7 t70 -86.95 114.59 23.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.629 0.252 . . . . 0.0 110.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -134.76 112.15 10.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.975 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' HG13 ' A' ' 4' ' ' VAL . 16.4 t -164.11 174.91 10.73 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.604 169.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 17.2 m -84.19 103.09 13.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.09 -117.14 4.32 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -144.77 140.67 28.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.951 0.375 . . . . 0.0 111.082 -178.256 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.7 t -98.24 117.32 32.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.42 122.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.989 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 61.49 41.51 12.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.076 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.9 m120 67.34 7.88 5.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.255 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -128.56 148.55 50.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -102.5 147.11 27.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.317 0.58 . . . . 0.0 111.845 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.479 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' CYS . 12.1 p . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.62 164.67 26.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.169 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 95.0 m-20 -59.27 133.11 55.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.235 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.75 -12.17 66.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.5 156.2 46.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.448 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.4 t80 -93.44 121.32 34.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.666 0.27 . . . . 0.0 110.869 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 4.3 p -129.07 126.66 23.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.915 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.49 172.09 7.18 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.725 2.284 . . . . 0.0 112.272 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 9.6 p-10 -55.56 121.51 39.09 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.401 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.23 -26.38 51.47 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.713 2.942 . . . . 0.0 113.671 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' C ' ' HE3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -68.3 -31.96 71.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -96.56 -45.47 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mpt? -114.48 0.61 14.08 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.3 152.91 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.69 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.81 119.93 30.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.206 0.527 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -122.74 112.15 17.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.673 0.749 . . . . 0.0 109.743 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 4' ' ' VAL . 14.4 t -162.5 155.96 20.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.747 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.99 102.44 14.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 -109.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.127 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -139.28 146.15 40.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.292 . . . . 0.0 110.799 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.45 110.99 23.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 26' ' ' ARG . 28.6 mt -136.14 127.49 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.965 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HG3' HG22 ' A' ' 25' ' ' ILE . 15.6 mtm180 62.65 33.44 15.66 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.62 0.368 . . . . 0.0 110.862 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 18.6 m120 61.97 20.65 11.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 110.811 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 32.5 mt-10 -116.38 156.23 27.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 38.4 t -102.66 119.68 39.25 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 . . . . . 0 C--N 1.323 -0.557 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.478 ' HB ' ' SG ' ' A' ' 20' ' ' CYS . 47.3 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -87.68 166.42 14.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.741 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -57.25 133.97 55.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.27 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -3.11 76.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.249 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.57 148.61 49.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.011 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -89.44 130.55 35.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.786 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.7 p -124.72 147.5 56.28 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.31 170.67 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.217 1.945 . . . . 0.0 111.568 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.79 112.59 2.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.057 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 -27.23 67.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.086 2.524 . . . . 0.0 112.499 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -67.45 -33.08 74.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.114 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.65 -45.62 6.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -102.23 -14.71 16.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 155.87 25.99 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -171.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -86.3 123.55 31.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -129.53 112.46 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.555 0.693 . . . . 0.0 110.357 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 28.9 t -162.21 175.04 12.08 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.593 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.2 m -84.63 105.27 15.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 160.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.97 7.99 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -135.7 134.01 38.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -99.07 112.16 24.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 109.691 176.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.7 mt -120.13 120.55 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.892 -174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 57.08 50.38 12.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.366 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 65.3 13.28 8.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.213 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.33 147.57 52.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.8 t -102.14 137.44 40.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.406 0.622 . . . . 0.0 112.255 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.722 179.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' CG1' ' HA3' ' A' ' 8' ' ' GLY . 15.8 t . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.84 0.352 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.97 158.43 35.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.148 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -60.48 124.45 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.79 -10.14 58.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.264 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.4 ' HA3' ' CG1' ' A' ' 4' ' ' VAL . . . -66.68 152.23 52.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.384 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 48.9 t80 -92.28 128.11 38.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 0.0 110.563 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.2 p -121.38 133.4 24.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.339 -0.392 . . . . 0.0 109.991 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.58 167.88 14.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 111.939 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -42.66 109.25 0.72 Allowed Pre-proline 0 C--O 1.237 0.423 0 O-C-N 124.263 0.977 . . . . 0.0 112.613 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.86 -18.62 42.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.344 2.696 . . . . 0.0 112.641 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -62.56 -39.16 92.78 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -97.54 -45.44 6.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.75 -175.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.0 mtt -108.22 8.04 27.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.75 162.24 5.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.786 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -86.33 121.85 29.48 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -124.89 112.89 17.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.865 0.84 . . . . 0.0 109.589 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 35.5 t -160.55 163.22 32.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.654 -173.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -92.63 103.55 15.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 161.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.3 -109.97 2.4 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.023 -170.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -139.83 138.71 36.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 110.782 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -98.93 111.17 23.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 109.963 176.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.14 129.82 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.986 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 58.82 43.28 18.57 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.398 0.436 . . . . 0.0 111.006 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 28.8 m120 60.61 26.27 15.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.304 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 35.5 tt0 -131.37 150.8 52.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -100.73 119.55 38.78 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.805 -174.197 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 121.334 0.588 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.8 -175.06 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.25 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 2.3 p-10 -51.53 132.6 30.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.333 0.587 . . . . 0.0 111.268 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.16 13.33 17.93 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.301 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.32 141.6 15.37 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.606 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.94 111.95 23.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.9 p -114.95 123.26 32.18 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.986 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.513 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 84.6 Cg_exo -53.94 164.43 2.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.915 2.41 . . . . 0.0 112.287 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 12.3 t70 -37.6 114.91 0.74 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 124.29 0.994 . . . . 0.0 112.711 -171.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 44.6 Cg_exo -58.56 -42.33 55.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.333 2.689 . . . . 0.0 114.028 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -81.26 -37.06 29.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.601 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -96.14 -35.93 11.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.858 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 11' ' ' PRO . 64.4 mtt -103.87 -21.96 13.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.18 144.69 6.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.566 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 14.6 t70 -98.93 106.64 18.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.731 0.301 . . . . 0.0 110.459 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.513 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 30.6 p-90 -132.06 112.19 12.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.692 0.758 . . . . 0.0 110.208 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.09 173.19 16.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.667 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 t -84.5 105.35 15.25 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.23 1.73 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.832 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 1.1 tmt_? -144.67 146.85 32.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 34.6 t -97.31 113.06 24.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.9 mt -126.6 117.71 48.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.0 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 59.46 43.42 16.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 110.65 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 20.0 m120 62.93 26.72 15.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.398 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -133.02 153.35 51.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.599 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 90.5 m -101.81 124.99 48.37 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.207 0.527 . . . . 0.0 110.629 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.733 178.293 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.623 HG13 ' SG ' ' A' ' 29' ' ' CYS . 4.1 p . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.51 171.84 9.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.202 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 5.2 p-10 -52.62 137.96 29.47 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.486 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.69 69.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.742 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.71 150.57 28.25 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.172 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 27' ' ' ASN . 78.6 t80 -89.92 122.77 33.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -109.81 132.33 21.44 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.06 166.16 17.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.443 2.096 . . . . 0.0 111.508 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 14' ' ' GLU . 21.1 t70 -45.46 113.08 1.8 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.049 0.843 . . . . 0.0 111.87 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.2 Cg_exo -59.45 -20.96 59.21 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.211 2.607 . . . . 0.0 113.326 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 34.9 mm-40 -74.98 -33.58 61.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.521 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -96.34 -45.28 6.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.349 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.15 -8.36 25.26 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 163.87 38.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.876 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.08 107.12 13.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -135.86 112.41 10.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.072 0.939 . . . . 0.0 111.035 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 88.6 m -158.96 166.7 31.2 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.9 m -84.9 103.76 14.25 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 162.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.89 -117.67 4.22 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.72 149.48 49.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.716 0.258 . . . . 0.0 110.598 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 42.9 t -97.84 109.46 22.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.85 111.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.975 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 61.65 44.69 8.69 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.42 0.45 . . . . 0.0 110.881 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 22.3 m120 62.77 28.21 16.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.396 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -132.17 144.29 50.57 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' A' ' 4' ' ' VAL . 92.4 m -101.25 119.0 38.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.056 -177.42 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 20' ' ' CYS . 6.6 p . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.0 167.15 20.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.325 -172.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.1 p-10 -59.26 137.21 58.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.201 0.524 . . . . 0.0 110.738 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.41 -13.39 56.9 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.533 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.46 150.31 49.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.365 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.75 124.87 39.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -116.78 134.65 22.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.984 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.543 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 30.4 Cg_endo -63.19 159.99 36.66 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 111.461 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.74 116.5 6.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.281 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.36 -28.9 55.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.538 2.825 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.93 -37.41 84.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.473 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.6 OUTLIER -97.04 -45.99 6.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 11' ' ' PRO . 2.3 mpt? -102.18 -14.41 17.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -172.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.91 167.63 36.19 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -88.71 107.3 18.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -133.35 112.18 11.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.829 0.823 . . . . 0.0 110.188 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 4' ' ' VAL . 64.2 m -160.05 170.74 20.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.086 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.67 104.61 15.55 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 160.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.54 -113.03 3.84 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.21 -171.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -133.3 152.26 51.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.66 -0.318 . . . . 0.0 111.153 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -97.79 109.65 22.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 62.9 mt -129.16 115.92 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.248 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 60.66 40.45 16.44 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.183 0.302 . . . . 0.0 110.687 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.75 29.49 19.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.279 0.562 . . . . 0.0 110.844 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ILE . 36.5 tt0 -132.61 145.57 51.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.293 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 93.6 m -100.71 122.73 43.84 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.902 -178.568 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.672 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 23.7 t . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.94 162.95 27.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.922 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 94.3 m-20 -63.28 126.98 29.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.961 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.09 -4.04 84.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.035 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.75 52.9 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 57.3 t80 -88.46 117.72 27.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 p -112.66 130.97 22.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.444 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.99 161.64 25.25 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.336 2.024 . . . . 0.0 111.136 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.3 t70 -51.07 123.11 18.88 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.761 0.663 . . . . 0.0 111.572 -172.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 49.2 Cg_exo -58.06 -20.85 47.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.431 2.754 . . . . 0.0 114.028 -176.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -80.84 -25.94 37.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.62 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -45.86 6.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -108.15 -10.32 15.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.12 166.42 35.57 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.818 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.5 109.12 20.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.894 0.378 . . . . 0.0 110.295 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -135.49 111.05 9.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.806 0.812 . . . . 0.0 110.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.5 m -160.75 173.63 15.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.733 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 106.02 18.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . 107.99 -106.79 2.43 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' A' ' 22' ' ' GLY . 8.4 mpt_? -137.39 152.32 49.51 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.337 0.255 . . . . 0.0 110.387 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.6 t -96.92 110.2 22.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.93 120.46 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.2 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 60.07 32.8 21.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.646 0.378 . . . . 0.0 110.744 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 27.2 m120 66.13 23.49 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.853 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.82 151.09 40.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.878 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 74.7 m -102.95 120.2 40.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.409 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' O ' ' HA3' ' A' ' 22' ' ' GLY . 28.2 mtm180 . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.78 158.81 28.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.3 p-10 -58.19 126.89 29.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.094 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.53 -7.47 57.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.195 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.74 139.5 22.99 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.846 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -80.87 127.6 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.989 0.423 . . . . 0.0 110.172 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 p -117.45 137.47 24.15 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.814 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.51 169.2 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.629 2.219 . . . . 0.0 111.57 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -46.63 108.39 0.84 Allowed Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 123.982 0.801 . . . . 0.0 111.953 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.57 -20.23 63.53 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.005 2.47 . . . . 0.0 112.854 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.74 -36.9 83.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.603 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -98.07 -45.99 6.04 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.552 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.0 -3.97 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.51 161.64 33.54 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.093 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -86.29 113.7 22.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -132.4 111.2 11.11 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.037 0.923 . . . . 0.0 110.021 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.9 t -162.31 161.11 27.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.13 103.39 15.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 161.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.05 -109.88 2.19 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.815 -170.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.72 140.62 27.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.79 111.82 23.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.476 0.655 . . . . 0.0 109.921 175.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.5 mt -124.45 121.57 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.024 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 59.74 44.68 13.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.195 0.521 . . . . 0.0 110.707 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.9 m120 63.63 18.86 11.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.663 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -119.82 142.28 48.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 19.8 t -101.31 119.26 38.49 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.307 -175.575 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.471 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.3 p . . . . . 0 C--O 1.225 -0.233 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.07 168.82 19.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -54.57 143.49 24.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.357 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.69 -10.15 65.88 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.995 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 146.99 45.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.751 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -91.0 125.93 35.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -123.43 137.97 29.36 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.302 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.21 157.48 39.74 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.407 2.071 . . . . 0.0 111.421 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.78 113.01 2.69 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.452 -172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.91 -25.22 51.81 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.469 2.779 . . . . 0.0 112.875 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.64 -39.33 91.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -97.41 -45.44 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.542 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -105.45 1.58 27.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.41 155.24 16.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.975 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.91 117.56 20.11 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.319 0.248 . . . . 0.0 110.546 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -138.41 113.05 8.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.104 0.954 . . . . 0.0 111.078 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 4' ' ' VAL . 39.9 t -162.03 173.14 14.82 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.166 168.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 3.8 m -86.96 102.06 14.02 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 161.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.24 -121.82 5.25 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.34 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -137.0 137.08 39.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.041 0.421 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -98.18 112.11 24.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.52 125.5 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.826 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 63.91 38.89 8.55 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.121 0.263 . . . . 0.0 111.004 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 m120 65.27 11.84 7.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.386 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -133.53 158.54 42.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.5 t -101.59 135.94 42.26 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.025 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.062 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.412 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.0 p . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 178.73 6.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.024 -173.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 6.7 m-20 -52.86 138.06 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.014 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.71 -9.27 71.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.568 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.41 135.11 49.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.111 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -92.16 111.41 22.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 110.449 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -111.38 137.92 21.22 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 29.5 Cg_endo -61.12 163.53 16.62 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.314 2.009 . . . . 0.0 110.956 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.55 111.42 2.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.881 0.738 . . . . 0.0 111.232 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.24 -21.99 38.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.253 2.635 . . . . 0.0 113.262 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.2 -34.03 59.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 75.5 mmtt -97.06 -45.96 6.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.2 mpt? -98.2 -31.32 12.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.618 0.247 . . . . 0.0 111.561 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.76 156.18 9.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.9 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.82 106.52 18.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -129.4 111.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.756 0.789 . . . . 0.0 111.259 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.412 ' SG ' HG13 ' A' ' 4' ' ' VAL . 7.8 t -163.58 173.78 12.58 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.518 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.78 104.74 16.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 159.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.68 -136.12 9.55 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -127.47 139.13 53.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.128 0.464 . . . . 0.0 110.752 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -97.92 110.89 23.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.36 115.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.815 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 26' ' ' ARG . 22.1 mtp180 61.76 44.53 8.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.446 0.466 . . . . 0.0 110.842 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.98 24.51 13.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.292 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 34.9 mt-10 -125.0 152.33 44.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.198 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.2 m -102.34 119.92 39.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.829 -179.223 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.446 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 10.9 p . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.71 174.68 6.11 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.634 0.254 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -55.55 135.84 50.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.203 0.525 . . . . 0.0 111.109 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.19 -6.31 72.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 158.96 45.51 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.871 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -90.56 133.48 35.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.8 p -139.59 142.33 31.35 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.24 160.41 26.9 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.376 2.051 . . . . 0.0 111.075 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.12 110.5 1.81 Allowed Pre-proline 0 C--N 1.327 -0.4 0 O-C-N 124.006 0.816 . . . . 0.0 111.557 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.66 -24.73 64.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.098 2.532 . . . . 0.0 112.178 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.94 -40.78 85.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.545 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.45 -46.67 5.68 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -178.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.3 mpt? -96.28 1.15 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.86 156.9 24.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.398 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.48 108.53 17.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.743 0.306 . . . . 0.0 110.705 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -127.39 113.42 16.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.583 0.706 . . . . 0.0 110.251 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 4' ' ' VAL . 44.7 t -161.85 173.28 14.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.367 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 33.2 m -93.45 103.44 15.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 155.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.21 -128.46 7.99 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -166.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -141.62 134.87 29.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.303 0.551 . . . . 0.0 111.129 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -97.61 114.4 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.311 0.577 . . . . 0.0 110.004 177.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -131.68 116.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.94 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 64.12 44.75 4.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 111.477 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 22.3 m120 74.66 0.82 3.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.349 173.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.35 158.4 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 53.8 t -102.87 145.09 30.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.598 0.713 . . . . 0.0 111.783 -175.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.929 -178.416 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.512 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.2 p . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.62 177.75 5.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -52.58 138.71 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.37 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' HA2' ' OE2' ' A' ' 28' ' ' GLU . . . 86.69 0.85 85.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.357 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 146.44 21.14 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.172 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -85.35 120.96 27.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.437 . . . . 0.0 110.199 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 p -119.38 138.04 26.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.24 164.06 15.74 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.633 2.222 . . . . 0.0 111.526 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.585 ' OD1' ' HG2' ' A' ' 14' ' ' GLU . 8.9 t70 -52.74 127.28 42.91 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.671 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.92 -17.87 39.47 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.426 2.751 . . . . 0.0 114.139 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 6.6 pt-20 -77.41 -31.19 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.808 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 37.6 mmtm -97.73 -42.86 7.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -113.49 6.35 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.713 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.8 167.45 14.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.905 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -81.84 103.66 11.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -124.14 111.49 15.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.705 0.764 . . . . 0.0 110.624 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.512 ' SG ' HG13 ' A' ' 4' ' ' VAL . 22.9 t -164.01 174.36 11.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.874 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.05 102.43 14.49 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 155.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.34 -128.8 6.71 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.047 -170.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 9.6 mmt180 -141.12 137.64 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.107 0.453 . . . . 0.0 111.372 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.48 111.69 23.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 110.617 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.91 117.64 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.68 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 62.5 46.31 5.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.96 0.409 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 m120 61.65 18.27 9.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.905 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' OE2' ' HA2' ' A' ' 7' ' ' GLY . 46.4 tp10 -131.38 142.34 50.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 54.1 t -102.77 136.06 43.29 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.046 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.772 -178.115 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.972 0.415 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -97.88 136.51 38.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.005 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 p -83.45 151.21 25.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.287 0.565 . . . . 0.0 110.99 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.15 146.79 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.991 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.75 165.89 23.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.262 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -59.52 135.95 57.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.092 0.472 . . . . 0.0 111.502 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.09 -6.54 82.6 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.013 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.24 163.38 54.58 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.453 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -98.0 129.56 44.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.865 0.364 . . . . 0.0 110.659 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.13 122.64 26.86 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.528 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD2' ' NE1' ' A' ' 19' ' ' TRP . 32.0 Cg_endo -62.04 169.05 8.08 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.863 2.375 . . . . 0.0 112.375 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.08 111.23 1.01 Allowed Pre-proline 0 N--CA 1.465 0.302 0 O-C-N 123.988 0.805 . . . . 0.0 112.512 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 54.0 Cg_exo -55.63 -27.87 62.71 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.374 2.716 . . . . 0.0 112.787 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -71.2 -36.83 72.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.838 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.18 -46.19 5.93 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -101.12 -16.69 16.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.289 . . . . 0.0 111.582 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 154.92 31.37 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.516 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 13' ' ' PRO . 4.7 p-10 -88.74 130.27 35.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.081 0.467 . . . . 0.0 110.43 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.447 ' NE1' ' HD2' ' A' ' 11' ' ' PRO . 1.6 p-90 -143.2 113.57 7.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.773 0.797 . . . . 0.0 109.965 176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.0 t -161.21 154.77 21.83 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.709 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.74 103.07 15.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 164.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.97 -105.09 1.13 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.067 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -144.33 144.71 31.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.673 0.236 . . . . 0.0 110.575 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.5 t -96.71 110.11 22.63 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.7 mt -130.06 122.61 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.91 -174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 59.34 40.06 21.57 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 110.663 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.0 m120 62.57 22.78 13.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.461 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.04 152.29 42.81 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.793 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.26 119.7 39.15 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -128.4 137.06 51.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.801 -174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -134.01 144.18 48.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.786 176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.996 -0.891 . . . . 0.0 111.221 -178.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.816 0.341 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -84.32 145.0 28.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.28 -177.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.6 m -135.26 168.93 18.26 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.481 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 20' ' ' CYS . 14.1 p -92.84 145.78 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 164.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -79.51 166.42 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.15 0.5 . . . . 0.0 111.544 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 21.2 t30 -59.76 125.33 23.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.622 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.18 -7.57 52.13 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.341 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.84 156.06 51.47 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.201 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -97.68 122.53 40.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.761 0.315 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 7.9 p -118.01 130.69 24.57 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 34.6 Cg_endo -62.98 166.65 13.77 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.28 1.987 . . . . 0.0 110.798 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.9 t70 -44.36 109.55 0.87 Allowed Pre-proline 0 C--N 1.329 -0.304 0 O-C-N 124.016 0.822 . . . . 0.0 111.281 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 31.6 Cg_exo -60.14 -29.67 89.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.163 2.575 . . . . 0.0 113.76 -171.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -82.49 -24.86 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.414 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -97.08 -45.21 6.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.537 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.5 mtt -110.47 3.76 19.89 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.88 142.47 13.16 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.543 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.1 117.58 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.524 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 5.9 p-90 -134.2 112.33 11.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.815 0.817 . . . . 0.0 110.549 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 42.9 t -161.07 159.46 29.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.115 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.79 103.81 14.56 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 163.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.92 -111.62 2.24 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.235 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -144.67 142.85 30.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.908 0.354 . . . . 0.0 110.819 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -98.71 111.51 23.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.06 0.457 . . . . 0.0 110.251 176.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 25' ' ' ILE . 3.3 mp -112.73 114.16 46.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.037 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.72 56.75 6.37 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.503 0.502 . . . . 0.0 111.361 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 23.9 m120 66.64 19.01 10.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.424 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 36.1 tt0 -129.13 145.38 51.31 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 36.6 t -100.75 128.14 46.91 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -127.34 138.47 53.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.247 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -119.17 144.14 46.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.141 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.197 -1.335 . . . . 0.0 111.077 -178.226 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -79.61 142.25 35.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.307 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 15.0 p 56.98 150.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.972 1.309 . . . . 0.0 113.294 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.702 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 22.1 t -92.63 133.38 34.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.751 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.32 163.93 21.89 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.885 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.3 p-10 -61.92 133.71 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.276 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.21 4.26 84.08 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.03 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.62 153.66 24.23 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.1 -0.572 . . . . 0.0 111.951 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.56 121.75 29.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.826 0.346 . . . . 0.0 110.813 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -109.0 126.93 28.25 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.61 167.9 17.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.479 2.119 . . . . 0.0 111.525 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 4.2 m-20 -42.07 107.17 0.5 Allowed Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 124.167 0.917 . . . . 0.0 112.889 -175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 48.1 Cg_exo -57.93 -26.42 74.46 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.168 2.579 . . . . 0.0 112.371 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 15' ' ' LYS . 7.0 pt-20 -57.07 -42.85 81.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.736 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' N ' ' HG3' ' A' ' 14' ' ' GLU . 47.1 mmtm -98.82 -46.4 5.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -94.0 -5.24 48.03 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.02 155.62 26.24 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.066 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 12.6 t70 -78.31 96.73 5.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.3 p-90 -125.63 112.28 15.96 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.161 0.981 . . . . 0.0 110.817 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 67.2 m -158.67 167.04 30.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.079 -1.418 . . . . 0.0 107.544 177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 4.3 m -84.47 104.38 14.43 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 165.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.37 -105.57 2.19 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -171.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -140.54 148.52 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.762 -0.258 . . . . 0.0 111.276 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 40.1 t -97.6 109.72 22.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.8 mt -128.8 110.64 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.377 -172.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 63.37 39.94 8.91 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.42 0.45 . . . . 0.0 110.352 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.3 m120 63.64 24.74 14.05 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.12 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -125.66 144.57 50.54 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 90.6 m -101.09 121.92 42.65 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.918 0.39 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -120.89 141.05 50.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.167 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -120.97 132.07 54.7 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.824 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.796 0 CA-C-O 118.729 -1.04 . . . . 0.0 112.045 -179.096 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.952 0.406 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.29 158.11 15.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.13 143.89 40.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.573 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.744 HG13 ' SG ' ' A' ' 20' ' ' CYS . 4.2 p -86.86 120.61 36.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.294 0.569 . . . . 0.0 109.679 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -87.13 -170.32 3.0 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.546 -170.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 25.7 p-10 -50.73 138.89 17.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.471 0.653 . . . . 0.0 111.885 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.5 71.67 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.787 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.33 153.07 49.02 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.148 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -99.05 131.07 45.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.013 0.435 . . . . 0.0 110.236 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.7 p -132.94 143.24 47.76 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.82 164.97 27.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.28 1.986 . . . . 0.0 111.171 173.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 3.0 p-10 -52.53 112.51 3.48 Favored Pre-proline 0 C--N 1.328 -0.361 0 O-C-N 123.718 0.636 . . . . 0.0 111.613 -177.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.5 Cg_exo -59.29 -21.51 60.76 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.492 2.794 . . . . 0.0 113.203 -175.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HG3' ' CD ' ' A' ' 15' ' ' LYS . 10.6 pt-20 -65.04 -40.57 95.0 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.124 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.3 mptm? -96.91 -45.92 6.42 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -98.05 0.23 45.81 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.78 161.76 23.64 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.949 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 13.3 t70 -89.48 114.16 25.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -137.55 109.25 7.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.523 0.678 . . . . 0.0 110.552 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.744 ' SG ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -164.87 174.37 10.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.08 172.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.38 104.99 14.87 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 162.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 -127.64 8.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -131.98 141.36 49.26 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 14.6 t -96.6 112.53 24.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.1 mt -122.8 106.12 17.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.217 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 54.42 55.39 8.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.351 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.8 m120 72.16 5.52 5.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.188 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -131.6 143.77 50.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 73.0 m -103.08 134.3 46.74 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.107 0.48 . . . . 0.0 111.588 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -118.23 143.85 46.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.094 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.73 140.52 42.03 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.473 -1.182 . . . . 0.0 111.838 -177.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.279 0.562 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -145.12 164.03 32.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.16 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 24.6 p -71.44 157.99 37.07 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.722 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 31.9 t -83.28 124.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -69.51 163.65 24.92 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.613 -173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -53.0 131.84 36.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.058 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.05 -5.12 83.27 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.185 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.21 169.9 54.66 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.516 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -97.98 134.37 41.18 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.912 0.387 . . . . 0.0 110.712 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -124.87 130.69 24.14 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.539 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.35 164.31 23.52 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.389 2.059 . . . . 0.0 111.092 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 56.5 m-20 -48.67 112.28 2.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 O-C-N 123.856 0.722 . . . . 0.0 112.016 -173.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 -27.3 52.2 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.348 2.699 . . . . 0.0 112.937 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.8 pt-20 -62.2 -40.69 96.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 5.3 tppp? -98.81 -46.22 5.73 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -175.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.3 mpt? -101.31 3.03 40.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.36 159.36 25.5 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.434 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' A' ' 24' ' ' CYS . 12.0 t70 -86.83 106.95 18.08 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -135.29 111.0 9.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.852 0.834 . . . . 0.0 110.627 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.584 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 33.2 m -160.06 163.17 34.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.469 -1.241 . . . . 0.0 108.847 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 33.7 m -83.78 105.61 14.82 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 166.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.93 -102.63 1.89 Allowed Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -171.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -143.96 149.58 36.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.989 0.116 . . . . 0.0 110.722 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 36.2 t -97.45 110.32 22.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.0 mt -128.28 111.59 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.211 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 59.81 48.91 8.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.756 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.23 24.56 14.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.008 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -133.19 150.74 51.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.824 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 81.5 m -100.74 119.04 38.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 30' ' ' ARG . 20.7 mtp180 -117.02 138.88 51.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.555 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -150.84 135.38 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.553 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.322 -1.265 . . . . 0.0 111.447 -178.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 121.177 0.513 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.2 pm0 -92.6 158.64 15.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.228 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.4 p -119.73 147.08 45.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.97 0.414 . . . . 0.0 110.259 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 20' ' ' CYS . 13.9 p -90.12 147.46 5.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -84.81 171.91 11.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.671 0.272 . . . . 0.0 111.25 -176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -56.79 133.5 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.573 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -14.21 65.41 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.632 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.16 139.99 38.94 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.176 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -82.78 119.21 24.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.045 0.45 . . . . 0.0 110.245 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -115.54 127.03 27.13 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.759 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 26.5 Cg_endo -60.58 160.03 25.78 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.507 2.138 . . . . 0.0 111.166 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 6.2 m-20 -45.07 108.11 0.72 Allowed Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 124.357 1.036 . . . . 0.0 112.423 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -54.34 -29.08 56.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.384 2.723 . . . . 0.0 112.947 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' HB3' ' A' ' 12' ' ' ASP . 12.5 pt-20 -58.62 -38.64 78.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.93 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 24.3 tptm -99.1 -46.16 5.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.411 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 2.4 mpt? -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -171.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.25 146.12 5.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.492 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -75.55 110.01 9.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.521 ' CZ3' ' HB ' ' A' ' 4' ' ' VAL . 14.8 p-90 -128.6 112.05 13.87 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.109 0.956 . . . . 0.0 110.02 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' HG12 ' A' ' 4' ' ' VAL . 5.7 t -162.46 154.53 18.78 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.864 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.57 101.96 12.51 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 163.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -109.68 2.06 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.744 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -144.86 140.07 28.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.5 t -95.8 110.29 22.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.7 mt -126.11 122.93 62.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.036 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 2.9 mmp_? 58.11 41.08 24.47 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.417 0.448 . . . . 0.0 110.358 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 66.66 19.36 10.79 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.131 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.21 151.98 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.7 t -100.48 123.42 44.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 109.909 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -127.95 146.96 50.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.167 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -116.72 151.13 37.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.942 178.39 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.918 0.39 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -117.95 147.69 42.91 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.465 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 10.2 p -99.37 151.66 20.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.013 0.435 . . . . 0.0 110.408 -176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' HB ' ' CZ3' ' A' ' 19' ' ' TRP . 8.8 p -84.18 148.34 5.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.934 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -69.82 166.12 20.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.0 111.13 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -61.33 136.45 58.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.545 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.94 1.43 78.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.067 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.49 162.84 54.25 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.397 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.7 t80 -95.88 136.44 36.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.46 . . . . 0.0 110.892 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -132.24 150.87 77.19 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 18.2 Cg_endo -58.88 170.47 2.69 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.374 2.049 . . . . 0.0 111.592 172.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.619 ' OD1' ' HD3' ' A' ' 15' ' ' LYS . 9.0 t70 -46.22 109.05 0.91 Allowed Pre-proline 0 N--CA 1.465 0.323 0 O-C-N 123.837 0.71 . . . . 0.0 111.427 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.45 -24.42 68.88 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.418 2.745 . . . . 0.0 113.887 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.65 -43.82 16.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.717 0.294 . . . . 0.0 110.93 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' HD3' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -86.74 -45.32 11.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.185 -176.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -92.78 -22.69 19.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.5 149.48 23.54 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.508 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.96 120.14 27.91 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.185 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.439 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 42.1 p-90 -125.25 113.18 17.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.767 0.794 . . . . 0.0 110.606 175.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 47.0 t -160.83 173.53 15.22 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.267 173.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.417 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 55.0 m -88.31 103.72 16.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 161.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.11 -117.51 3.67 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.76 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -144.94 135.57 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.854 0.327 . . . . 0.0 111.232 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -103.65 118.1 35.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.272 0.558 . . . . 0.0 109.725 175.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.416 HG22 ' HG3' ' A' ' 26' ' ' ARG . 47.7 mt -136.32 130.23 47.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.213 -174.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HG3' HG22 ' A' ' 25' ' ' ILE . 18.7 mtm180 65.76 36.64 6.11 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.556 0.342 . . . . 0.0 111.002 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 21.3 m120 64.5 15.93 9.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.057 0.456 . . . . 0.0 111.055 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -132.94 149.71 52.22 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 46.5 t -101.74 134.99 44.04 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.706 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -120.99 151.36 39.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.783 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -118.53 106.41 12.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.737 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.504 -1.164 . . . . 0.0 111.515 179.338 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.656 0.265 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 11.8 pt-20 -82.09 167.76 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 2' ' ' GLU . 7.7 p 52.9 172.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.165 0.986 . . . . 0.0 113.047 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.3 p -87.37 145.15 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.008 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -75.31 165.84 24.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.159 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -59.99 145.3 46.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.39 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.02 -11.24 67.73 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.641 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.28 142.3 40.79 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.816 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -84.34 131.94 34.65 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.5 p -136.01 142.52 40.56 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.71 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.04 158.4 43.88 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.349 2.033 . . . . 0.0 111.01 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -55.45 118.5 19.18 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.59 -174.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.68 -28.74 48.11 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.702 2.935 . . . . 0.0 113.437 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.63 -32.92 74.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -96.6 -45.85 6.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 86.4 mmm -110.56 0.68 17.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.64 30.71 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.214 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 22.7 t70 -86.95 114.59 23.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.629 0.252 . . . . 0.0 110.354 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 21.6 p-90 -134.76 112.15 10.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.975 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' SG ' HG13 ' A' ' 4' ' ' VAL . 16.4 t -164.11 174.91 10.73 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.604 169.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 17.2 m -84.19 103.09 13.1 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 159.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.09 -117.14 4.32 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -144.77 140.67 28.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.951 0.375 . . . . 0.0 111.082 -178.256 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.7 t -98.24 117.32 32.37 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.42 122.48 40.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.324 -0.398 . . . . 0.0 109.989 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 61.49 41.51 12.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.826 0.346 . . . . 0.0 111.076 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 27.9 m120 67.34 7.88 5.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.255 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -128.56 148.55 50.77 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -102.5 147.11 27.16 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.317 0.58 . . . . 0.0 111.845 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -131.09 149.31 52.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -125.82 142.78 51.35 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.026 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.878 0 CA-C-O 119.015 -0.88 . . . . 0.0 111.232 -179.389 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -145.48 119.06 9.11 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.9 p -112.44 148.95 33.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.043 0.449 . . . . 0.0 110.267 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 20' ' ' CYS . 12.1 p -85.38 145.99 7.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -73.62 164.67 26.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.169 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 95.0 m-20 -59.27 133.11 55.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.235 -176.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.75 -12.17 66.08 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.5 156.2 46.22 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.448 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 79.4 t80 -93.44 121.32 34.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.666 0.27 . . . . 0.0 110.869 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 4.3 p -129.07 126.66 23.19 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.915 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.49 172.09 7.18 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.725 2.284 . . . . 0.0 112.272 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 15' ' ' LYS . 9.6 p-10 -55.56 121.51 39.09 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.401 -177.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -55.23 -26.38 51.47 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.713 2.942 . . . . 0.0 113.671 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' C ' ' HE3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -68.3 -31.96 71.75 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.434 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -96.56 -45.47 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 15' ' ' LYS . 1.2 mpt? -114.48 0.61 14.08 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.3 152.91 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.69 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.81 119.93 30.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.206 0.527 . . . . 0.0 110.72 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -122.74 112.15 17.58 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.673 0.749 . . . . 0.0 109.743 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.511 ' HA ' HG12 ' A' ' 4' ' ' VAL . 14.4 t -162.5 155.96 20.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.747 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.99 102.44 14.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 162.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 -109.11 1.96 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.127 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -139.28 146.15 40.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.714 0.292 . . . . 0.0 110.799 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.7 t -97.45 110.99 23.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.455 HG22 ' HG3' ' A' ' 26' ' ' ARG . 28.6 mt -136.14 127.49 43.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.965 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HG3' HG22 ' A' ' 25' ' ' ILE . 15.6 mtm180 62.65 33.44 15.66 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.62 0.368 . . . . 0.0 110.862 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 18.6 m120 61.97 20.65 11.72 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.33 0.586 . . . . 0.0 110.811 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 32.5 mt-10 -116.38 156.23 27.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.642 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 38.4 t -102.66 119.68 39.25 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -132.46 151.83 51.75 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -98.0 142.21 30.0 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.592 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.334 -1.259 . . . . 0.0 111.265 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.058 0.456 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -104.46 156.97 17.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.047 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.8 p -136.95 170.66 15.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.848 0.356 . . . . 0.0 110.446 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.478 ' HB ' ' SG ' ' A' ' 20' ' ' CYS . 47.3 t -77.9 147.05 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.112 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -87.68 166.42 14.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.741 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -57.25 133.97 55.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.27 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.75 -3.11 76.67 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.249 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.57 148.61 49.89 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.011 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -89.44 130.55 35.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.786 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.7 p -124.72 147.5 56.28 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.31 170.67 9.01 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.217 1.945 . . . . 0.0 111.568 173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -48.79 112.59 2.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.057 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 -27.23 67.99 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.086 2.524 . . . . 0.0 112.499 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -67.45 -33.08 74.41 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.114 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.65 -45.62 6.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -102.23 -14.71 16.89 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 155.87 25.99 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -171.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -86.3 123.55 31.68 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -129.53 112.46 13.77 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.555 0.693 . . . . 0.0 110.357 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 28.9 t -162.21 175.04 12.08 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.593 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.2 m -84.63 105.27 15.31 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 160.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.97 7.99 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 -172.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -135.7 134.01 38.68 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -99.07 112.16 24.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 109.691 176.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.7 mt -120.13 120.55 63.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.892 -174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 57.08 50.38 12.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.366 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.5 m120 65.3 13.28 8.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.213 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -132.33 147.57 52.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 43.8 t -102.14 137.44 40.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.406 0.622 . . . . 0.0 112.255 -175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -131.1 147.25 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.722 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -129.06 151.54 49.63 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.529 -1.151 . . . . 0.0 111.867 -179.238 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.804 0.335 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.76 156.79 21.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.444 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.7 p -99.84 163.2 12.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.916 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' CG1' ' HA3' ' A' ' 8' ' ' GLY . 15.8 t -91.49 146.57 6.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.352 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.97 158.43 35.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.148 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -60.48 124.45 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.62 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.79 -10.14 58.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.264 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.4 ' HA3' ' CG1' ' A' ' 4' ' ' VAL . . . -66.68 152.23 52.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.384 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 48.9 t80 -92.28 128.11 38.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 0.0 110.563 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.2 p -121.38 133.4 24.2 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.339 -0.392 . . . . 0.0 109.991 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.58 167.88 14.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.631 2.221 . . . . 0.0 111.939 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -42.66 109.25 0.72 Allowed Pre-proline 0 C--O 1.237 0.423 0 O-C-N 124.263 0.977 . . . . 0.0 112.613 -176.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.86 -18.62 42.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.344 2.696 . . . . 0.0 112.641 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -62.56 -39.16 92.78 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -97.54 -45.44 6.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.75 -175.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.0 mtt -108.22 8.04 27.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.75 162.24 5.36 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.786 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -86.33 121.85 29.48 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -124.89 112.89 17.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.865 0.84 . . . . 0.0 109.589 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 35.5 t -160.55 163.22 32.92 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.654 -173.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -92.63 103.55 15.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 161.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.3 -109.97 2.4 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.023 -170.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -139.83 138.71 36.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.459 0.171 . . . . 0.0 110.782 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -98.93 111.17 23.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.186 0.517 . . . . 0.0 109.963 176.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.14 129.82 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.986 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 58.82 43.28 18.57 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.398 0.436 . . . . 0.0 111.006 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 28.8 m120 60.61 26.27 15.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.304 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 35.5 tt0 -131.37 150.8 52.0 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -100.73 119.55 38.78 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -125.04 144.63 50.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.805 -174.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -144.13 147.16 33.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.652 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.467 -1.185 . . . . 0.0 111.895 -178.769 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.757 0.313 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.34 136.13 39.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.768 0.318 . . . . 0.0 110.503 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -88.04 141.77 28.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.858 0.361 . . . . 0.0 110.083 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.7 p -80.22 121.62 33.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.334 0.588 . . . . 0.0 110.796 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.8 -175.06 4.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.25 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 2.3 p-10 -51.53 132.6 30.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.333 0.587 . . . . 0.0 111.268 176.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.16 13.33 17.93 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.301 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.32 141.6 15.37 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.606 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -93.94 111.95 23.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.119 0.485 . . . . 0.0 110.178 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 2.9 p -114.95 123.26 32.18 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.986 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.513 ' HD2' ' HE1' ' A' ' 19' ' ' TRP . 84.6 Cg_exo -53.94 164.43 2.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.915 2.41 . . . . 0.0 112.287 174.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 12.3 t70 -37.6 114.91 0.74 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 124.29 0.994 . . . . 0.0 112.711 -171.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 44.6 Cg_exo -58.56 -42.33 55.67 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.333 2.689 . . . . 0.0 114.028 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -81.26 -37.06 29.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.601 -172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -96.14 -35.93 11.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.858 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 11' ' ' PRO . 64.4 mtt -103.87 -21.96 13.57 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -174.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.18 144.69 6.51 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.566 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 14.6 t70 -98.93 106.64 18.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.731 0.301 . . . . 0.0 110.459 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.513 ' HE1' ' HD2' ' A' ' 11' ' ' PRO . 30.6 p-90 -132.06 112.19 12.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.692 0.758 . . . . 0.0 110.208 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 33.2 m -160.09 173.19 16.19 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.667 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.5 t -84.5 105.35 15.25 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.9 -102.23 1.73 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.832 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 1.1 tmt_? -144.67 146.85 32.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 34.6 t -97.31 113.06 24.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.9 mt -126.6 117.71 48.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.0 -176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 59.46 43.42 16.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 110.65 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 20.0 m120 62.93 26.72 15.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.398 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -133.02 153.35 51.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.599 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 90.5 m -101.81 124.99 48.37 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.207 0.527 . . . . 0.0 110.629 -176.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -106.39 113.85 27.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.733 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.65 97.21 7.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.675 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.284 -1.287 . . . . 0.0 111.308 -177.173 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.89 0.376 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -85.77 143.29 28.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.28 . . . . 0.0 110.255 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.514 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 31.6 p -118.81 158.14 26.2 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.865 0.364 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.623 HG13 ' SG ' ' A' ' 29' ' ' CYS . 4.1 p -104.73 129.04 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.51 171.84 9.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.202 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 5.2 p-10 -52.62 137.96 29.47 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.486 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.69 69.16 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.742 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.71 150.57 28.25 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.172 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 27' ' ' ASN . 78.6 t80 -89.92 122.77 33.26 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -109.81 132.33 21.44 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.06 166.16 17.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.443 2.096 . . . . 0.0 111.508 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 14' ' ' GLU . 21.1 t70 -45.46 113.08 1.8 Allowed Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.049 0.843 . . . . 0.0 111.87 -174.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 24' ' ' CYS . 32.2 Cg_exo -59.45 -20.96 59.21 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.211 2.607 . . . . 0.0 113.326 -176.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 34.9 mm-40 -74.98 -33.58 61.89 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.865 0.364 . . . . 0.0 110.521 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -96.34 -45.28 6.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.349 -178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.15 -8.36 25.26 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 163.87 38.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.876 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.08 107.12 13.62 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -135.86 112.41 10.01 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 122.072 0.939 . . . . 0.0 111.035 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 88.6 m -158.96 166.7 31.2 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.9 m -84.9 103.76 14.25 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 162.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.89 -117.67 4.22 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.72 149.48 49.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.716 0.258 . . . . 0.0 110.598 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 13' ' ' PRO . 42.9 t -97.84 109.46 22.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.85 111.49 27.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.975 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? 61.65 44.69 8.69 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.42 0.45 . . . . 0.0 110.881 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 22.3 m120 62.77 28.21 16.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.396 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -132.17 144.29 50.57 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' A' ' 4' ' ' VAL . 92.4 m -101.25 119.0 38.09 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -123.09 143.94 49.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.056 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -134.87 142.46 46.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -1.32 . . . . 0.0 111.235 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.0 t . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.6 119.1 16.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.979 0.419 . . . . 0.0 110.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -88.41 140.15 29.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.921 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 20' ' ' CYS . 6.6 p -76.21 130.38 36.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.74 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.0 167.15 20.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.325 -172.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 4.1 p-10 -59.26 137.21 58.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.201 0.524 . . . . 0.0 110.738 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.41 -13.39 56.9 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.533 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.46 150.31 49.59 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.365 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.75 124.87 39.04 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -116.78 134.65 22.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 116.272 -0.422 . . . . 0.0 109.984 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.543 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 30.4 Cg_endo -63.19 159.99 36.66 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 111.461 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.74 116.5 6.2 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.287 -0.869 . . . . 0.0 112.281 -173.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.36 -28.9 55.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.538 2.825 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -61.93 -37.41 84.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.954 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.473 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.6 OUTLIER -97.04 -45.99 6.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 11' ' ' PRO . 2.3 mpt? -102.18 -14.41 17.04 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -172.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.91 167.63 36.19 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.367 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -88.71 107.3 18.87 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -133.35 112.18 11.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.829 0.823 . . . . 0.0 110.188 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 4' ' ' VAL . 64.2 m -160.05 170.74 20.65 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.086 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.67 104.61 15.55 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 160.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.54 -113.03 3.84 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.21 -171.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -133.3 152.26 51.92 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.66 -0.318 . . . . 0.0 111.153 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.3 t -97.79 109.65 22.36 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 62.9 mt -129.16 115.92 37.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.248 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 60.66 40.45 16.44 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.183 0.302 . . . . 0.0 110.687 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.75 29.49 19.05 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.279 0.562 . . . . 0.0 110.844 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 25' ' ' ILE . 36.5 tt0 -132.61 145.57 51.21 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.293 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 93.6 m -100.71 122.73 43.84 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -126.11 140.97 52.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.902 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -107.13 161.02 15.13 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.14 -177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.893 -0.949 . . . . 0.0 111.29 179.812 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -88.24 135.86 33.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 0.0 110.159 176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 30.0 p -94.25 156.33 16.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.91 0.386 . . . . 0.0 110.538 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 ' HB ' ' SG ' ' A' ' 29' ' ' CYS . 23.7 t -83.35 140.06 16.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.668 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -69.94 162.95 27.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.922 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 94.3 m-20 -63.28 126.98 29.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.961 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.09 -4.04 84.56 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.035 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.75 52.9 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 27' ' ' ASN . 57.3 t80 -88.46 117.72 27.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.081 0.467 . . . . 0.0 110.929 -177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 p -112.66 130.97 22.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.444 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.99 161.64 25.25 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.336 2.024 . . . . 0.0 111.136 175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 13.3 t70 -51.07 123.11 18.88 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.761 0.663 . . . . 0.0 111.572 -172.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 49.2 Cg_exo -58.06 -20.85 47.65 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.431 2.754 . . . . 0.0 114.028 -176.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -80.84 -25.94 37.38 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.62 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.16 -45.86 6.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -108.15 -10.32 15.44 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.12 166.42 35.57 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.818 -176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.5 109.12 20.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.894 0.378 . . . . 0.0 110.295 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -135.49 111.05 9.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.806 0.812 . . . . 0.0 110.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.5 m -160.75 173.63 15.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.733 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.48 106.02 18.18 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . 107.99 -106.79 2.43 Favored Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.3 -174.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' A' ' 22' ' ' GLY . 8.4 mpt_? -137.39 152.32 49.51 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 122.337 0.255 . . . . 0.0 110.387 177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.6 t -96.92 110.2 22.77 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 172.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.0 mt -132.93 120.46 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.2 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 60.07 32.8 21.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.646 0.378 . . . . 0.0 110.744 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 27.2 m120 66.13 23.49 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.853 -176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -121.82 151.09 40.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.878 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB ' ' A' ' 4' ' ' VAL . 74.7 m -102.95 120.2 40.2 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.409 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' O ' ' HA3' ' A' ' 22' ' ' GLY . 28.2 mtm180 -118.77 130.29 55.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -117.78 138.59 51.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.78 0.324 . . . . 0.0 110.307 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.921 -0.933 . . . . 0.0 111.32 -178.874 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 120.741 0.305 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.86 136.64 33.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.413 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.1 p 52.67 -177.23 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.164 0.985 . . . . 0.0 112.652 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.36 143.6 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 170.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.78 158.81 28.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 15.3 p-10 -58.19 126.89 29.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.094 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.53 -7.47 57.98 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.195 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -77.74 139.5 22.99 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.846 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -80.87 127.6 32.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.989 0.423 . . . . 0.0 110.172 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 p -117.45 137.47 24.15 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.814 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.51 169.2 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.629 2.219 . . . . 0.0 111.57 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -46.63 108.39 0.84 Allowed Pre-proline 0 C--N 1.327 -0.393 0 O-C-N 123.982 0.801 . . . . 0.0 111.953 -176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.57 -20.23 63.53 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.005 2.47 . . . . 0.0 112.854 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.74 -36.9 83.53 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.603 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -98.07 -45.99 6.04 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.552 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -96.0 -3.97 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.51 161.64 33.54 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.093 -177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -86.29 113.7 22.5 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -132.4 111.2 11.11 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.037 0.923 . . . . 0.0 110.021 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 24' ' ' CYS . 28.9 t -162.31 161.11 27.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.195 -1.366 . . . . 0.0 108.021 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.4 m -88.13 103.39 15.7 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 161.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.05 -109.88 2.19 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.815 -170.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.72 140.62 27.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -97.79 111.82 23.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.476 0.655 . . . . 0.0 109.921 175.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.5 mt -124.45 121.57 61.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.024 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 59.74 44.68 13.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.195 0.521 . . . . 0.0 110.707 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.9 m120 63.63 18.86 11.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.663 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -119.82 142.28 48.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 19.8 t -101.31 119.26 38.49 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -113.8 128.55 56.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.307 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -115.53 106.47 13.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.627 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.932 -0.926 . . . . 0.0 111.43 177.406 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.476 0.829 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -64.89 140.34 58.86 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.505 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HB2' ' C ' ' A' ' 20' ' ' CYS . 24.9 p -115.36 151.78 34.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.345 0.593 . . . . 0.0 111.749 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.3 p -82.2 148.81 5.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.483 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -78.07 168.82 19.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -54.57 143.49 24.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.357 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.69 -10.15 65.88 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.995 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.99 146.99 45.61 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.751 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -91.0 125.93 35.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -123.43 137.97 29.36 Favored Pre-proline 0 C--N 1.317 -0.819 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.302 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.21 157.48 39.74 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.407 2.071 . . . . 0.0 111.421 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.78 113.01 2.69 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.452 -172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.91 -25.22 51.81 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.469 2.779 . . . . 0.0 112.875 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.64 -39.33 91.33 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.634 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -97.41 -45.44 6.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.542 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -105.45 1.58 27.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.41 155.24 16.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.975 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -78.91 117.56 20.11 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.319 0.248 . . . . 0.0 110.546 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -138.41 113.05 8.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.104 0.954 . . . . 0.0 111.078 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.55 ' C ' ' HB2' ' A' ' 3' ' ' CYS . 39.9 t -162.03 173.14 14.82 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.695 -1.139 . . . . 0.0 108.166 168.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 3.8 m -86.96 102.06 14.02 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 161.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.24 -121.82 5.25 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.34 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -137.0 137.08 39.05 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.041 0.421 . . . . 0.0 111.901 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 43.2 t -98.18 112.11 24.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.6 mt -133.52 125.5 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.826 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 63.91 38.89 8.55 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.121 0.263 . . . . 0.0 111.004 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 m120 65.27 11.84 7.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.386 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -133.53 158.54 42.88 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.5 t -101.59 135.94 42.26 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.025 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.54 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -116.8 150.6 38.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.062 -177.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -87.47 -15.84 36.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.172 0.511 . . . . 0.0 109.858 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.791 -1.005 . . . . 0.0 111.592 179.48 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.025 0.44 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.99 147.25 45.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.474 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 31.8 m -106.85 160.62 15.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.933 0.397 . . . . 0.0 110.948 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.412 HG13 ' SG ' ' A' ' 20' ' ' CYS . 9.0 p -79.54 136.77 22.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.459 176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 178.73 6.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.024 -173.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 29' ' ' CYS . 6.7 m-20 -52.86 138.06 30.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.014 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.71 -9.27 71.1 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.568 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.41 135.11 49.99 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.111 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -92.16 111.41 22.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.124 0.488 . . . . 0.0 110.449 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -111.38 137.92 21.22 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 29.5 Cg_endo -61.12 163.53 16.62 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.314 2.009 . . . . 0.0 110.956 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.55 111.42 2.01 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 123.881 0.738 . . . . 0.0 111.232 -173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.24 -21.99 38.63 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.253 2.635 . . . . 0.0 113.262 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -76.2 -34.03 59.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.026 0.441 . . . . 0.0 110.646 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 75.5 mmtt -97.06 -45.96 6.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.232 -174.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.2 mpt? -98.2 -31.32 12.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.618 0.247 . . . . 0.0 111.561 -175.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.76 156.18 9.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.9 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.82 106.52 18.53 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -129.4 111.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.756 0.789 . . . . 0.0 111.259 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.412 ' SG ' HG13 ' A' ' 4' ' ' VAL . 7.8 t -163.58 173.78 12.58 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.518 169.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.1 m -98.78 104.74 16.8 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 159.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.68 -136.12 9.55 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -169.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -127.47 139.13 53.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.128 0.464 . . . . 0.0 110.752 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -97.92 110.89 23.38 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.36 115.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.815 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 26' ' ' ARG . 22.1 mtp180 61.76 44.53 8.6 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.446 0.466 . . . . 0.0 110.842 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 m120 63.98 24.51 13.63 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.292 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 34.9 mt-10 -125.0 152.33 44.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.198 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 6' ' ' ASN . 4.2 m -102.34 119.92 39.63 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.949 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -131.0 111.56 12.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.829 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -96.28 70.29 2.73 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.604 -1.109 . . . . 0.0 111.452 -176.895 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.908 0.385 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -115.87 141.77 47.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.9 p -94.23 148.24 22.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.74 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.446 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 10.9 p -75.81 147.94 7.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 170.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -99.71 174.68 6.11 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.634 0.254 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -55.55 135.84 50.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.203 0.525 . . . . 0.0 111.109 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.19 -6.31 72.42 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.972 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.75 158.96 45.51 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.871 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -90.56 133.48 35.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.05 0.452 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 1.8 p -139.59 142.33 31.35 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.255 176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.24 160.41 26.9 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.376 2.051 . . . . 0.0 111.075 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.12 110.5 1.81 Allowed Pre-proline 0 C--N 1.327 -0.4 0 O-C-N 124.006 0.816 . . . . 0.0 111.557 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.66 -24.73 64.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.098 2.532 . . . . 0.0 112.178 -178.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -58.94 -40.78 85.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.545 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -98.45 -46.67 5.68 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -178.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.521 ' SD ' ' HB2' ' A' ' 15' ' ' LYS . 2.3 mpt? -96.28 1.15 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -170.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.86 156.9 24.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.398 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.48 108.53 17.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.743 0.306 . . . . 0.0 110.705 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.3 p-90 -127.39 113.42 16.2 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.583 0.706 . . . . 0.0 110.251 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 4' ' ' VAL . 44.7 t -161.85 173.28 14.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.367 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.43 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 33.2 m -93.45 103.44 15.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 155.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.21 -128.46 7.99 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -166.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -141.62 134.87 29.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.303 0.551 . . . . 0.0 111.129 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -97.61 114.4 26.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.311 0.577 . . . . 0.0 110.004 177.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 59.0 mt -131.68 116.33 30.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.94 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 64.12 44.75 4.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.27 0.557 . . . . 0.0 111.477 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 22.3 m120 74.66 0.82 3.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.349 173.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.35 158.4 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 53.8 t -102.87 145.09 30.32 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.598 0.713 . . . . 0.0 111.783 -175.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -128.1 147.28 50.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.929 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -144.2 153.01 41.64 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 121.094 -0.243 . . . . 0.0 110.706 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.915 -1.492 . . . . 0.0 111.02 178.428 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.771 0.32 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.24 134.69 50.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.188 0.518 . . . . 0.0 110.48 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.3 p -111.04 153.04 26.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.704 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.512 HG13 ' SG ' ' A' ' 20' ' ' CYS . 12.2 p -79.79 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -98.62 177.75 5.21 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -52.58 138.71 27.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.37 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' HA2' ' OE2' ' A' ' 28' ' ' GLU . . . 86.69 0.85 85.83 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.357 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.13 146.44 21.14 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.172 178.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -85.35 120.96 27.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.019 0.437 . . . . 0.0 110.199 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 p -119.38 138.04 26.02 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.939 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.24 164.06 15.74 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.633 2.222 . . . . 0.0 111.526 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.585 ' OD1' ' HG2' ' A' ' 14' ' ' GLU . 8.9 t70 -52.74 127.28 42.91 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.671 -172.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.92 -17.87 39.47 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.426 2.751 . . . . 0.0 114.139 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 6.6 pt-20 -77.41 -31.19 53.9 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.808 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 14' ' ' GLU . 37.6 mmtm -97.73 -42.86 7.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -113.49 6.35 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.713 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.8 167.45 14.84 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.905 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -81.84 103.66 11.67 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -124.14 111.49 15.97 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.705 0.764 . . . . 0.0 110.624 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.512 ' SG ' HG13 ' A' ' 4' ' ' VAL . 22.9 t -164.01 174.36 11.48 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.874 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -94.05 102.43 14.49 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 155.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.34 -128.8 6.71 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.047 -170.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 9.6 mmt180 -141.12 137.64 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.107 0.453 . . . . 0.0 111.372 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -98.48 111.69 23.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 110.617 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.91 117.64 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.68 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 62.5 46.31 5.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.96 0.409 . . . . 0.0 110.808 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 m120 61.65 18.27 9.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.905 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' OE2' ' HA2' ' A' ' 7' ' ' GLY . 46.4 tp10 -131.38 142.34 50.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' ARG . 54.1 t -102.77 136.06 43.29 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.046 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -140.16 -179.61 6.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.772 -178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -130.39 163.24 27.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.543 -1.143 . . . . 0.0 112.399 177.195 . . . . . . . . 0 0 . 1 stop_ save_